Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008757	b-diffmik	— (—)	3197	10800	99.99%	Distribution not available
3008757	b-diff-mik	— (—)	1828	5206	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial Sepsis

852

1634

4.42

313.16

4.3

3.5

—

L04AX Other immunosuppressants

908

2316

4.00

311.77

3.8

3.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

1588

1987

4.52

307.65

4.0

3.1

—

Inflammatory bowel disease treatment related agents

1633

2384

3.86

307.65

3.7

3.4

—

Explicit Sepsis

986

1650

5.62

307.65

4.4

3.5

—

Other septicaemia

892

1213

7.20

307.65

4.3

3.2

—

Bacterial infection, other or unspecified, including avohilmo

1378

1659

7.05

307.65

4.7

3.1

—

First line medication for Crohn's disease

1605

1895

4.63

307.65

4.0

3.2

—

Other septicaemia, including avohilmo

902

1232

7.13

307.65

4.4

3.2

—

ILD medications

1667

2034

4.49

307.65

4.2

3.1

—

Explicit Sepsis, including avohilmo

996

1683

5.54

307.65

4.4

3.5

—

Oral corticosteroids

1555

2297

4.03

307.65

3.7

3.4

—

Transplanted organ and tissue status

367

336

11.85

307.65

8.2

3.3

—

Second line medication for Crohn's disease

951

2354

4.13

307.65

3.7

3.5

—

Oxycodone

778

1389

4.92

307.65

3.8

3.7

—

ILD medications: immunosuppressive drugs

1225

1802

6.32

307.65

4.3

3.1

—

Bacterial infection, other or unspecified

1319

1566

7.38

307.65

4.9

3.1

—

Septicaemia

968

1321

6.92

307.65

4.3

3.2

—

Non-Hodgkin lymphoma, all, including Hilmo

350

358

10.33

306.71

5.9

2.7

—

Any gastric operation

797

748

5.41

298.26

3.9

2.3

—

GASTRO-related operations

797

748

5.41

298.26

3.9

2.3

—

Certain infectious and parasitic diseases

1051

1410

3.78

264.38

4.2

2.7

—

Malignant neoplasm

1023

1664

3.65

261.30

4.7

2.4

—

Implicit bacterial Sepsis

726

1487

4.29

260.33

4.3

3.6

—

Malignant neoplasm

1021

1674

3.62

257.97

4.7

2.4

—

Lymphoid leukaemia

264

236

12.55

256.63

10.5

3.6

—

Anaemias

339

186

11.94

256.53

4.8

1.5

—

Malignant neoplasm, including Hilmo

1019

1682

3.57

252.46

4.7

2.3

—

Implicit bacterial Sepsis, including avohilmo

758

1589

4.06

250.72

4.2

3.6

—

Malignant neoplasm, wide definition

1009

1702

3.50

242.16

4.7

2.4

—

Secondary uncertain malignant neoplasm

310

376

8.62

237.88

4.0

2.7

—

Chronic lymphocytic leukaemia

163

24.08

221.17

10.4

3.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

163

24.08

221.17

10.4

3.1

—

Chronic lymphocytic leukaemia, helper endpoint

163

24.08

221.17

10.4

3.1

—

Any event in cancer register

1016

1875

3.20

214.37

4.6

2.5

—

Aplastic and other anaemias

769

2093

3.43

205.89

4.9

3.5

—

Implicit Sepsis

949

2277

3.11

205.70

4.0

3.4

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

311

450

7.18

204.61

3.8

2.6

—

Secondary and unspecified malignant neoplasm of lymph nodes

223

220

10.72

200.70

4.4

2.9

—

Abnormal findings on diagnostic imaging of lung

764

2195

3.37

200.12

4.5

3.6

—

Infections, IBD-co-morbidities

301

249

8.75

197.79

5.5

3.5

—

Myelodysplastic syndrome, including Hilmo

145

22.38

192.00

11.6

3.3

—

ILD medications: azathioprine

258

328

8.12

189.96

3.8

3.0

—

L04AA Selective immunosuppressants

410

841

5.03

187.27

5.1

3.8

—

Erysipelas

663

1623

3.57

186.84

3.7

3.1

—

Non-follicular lymphoma

273

402

7.22

177.79

5.3

4.0

—

Other anaemias

684

1998

3.27

170.62

4.9

3.5

—

Renal failure

745

2056

3.15

170.41

4.3

3.7

—

Other and unspecified anaemias

679

1989

3.27

169.54

4.9

3.5

—

Rare circulating lymphoid malignancy, including Hilmo

127

22.12

167.80

9.9

3.2

—

General symptoms and signs

1084

2000

2.74

167.66

4.2

3.0

—

Azathioprine

258

386

6.89

164.34

3.8

—

Autoimmune diseases excluding thyroid diseases

1156

2471

2.56

161.38

3.4

3.7

—

Multiple myeloma, including Hilmo

152

120

13.72

158.90

5.0

3.0

—

COPD/asthma related infections

997

1816

2.77

157.81

4.2

2.9

—

COPD/asthma/ILD related infections

997

1816

2.77

157.81

4.2

2.9

—

Non-Hodgkin lymphoma, all

152

122

13.47

157.27

7.1

2.9

—

Autoimmune diseases excluding thyroid diseases, strict definition

1119

2395

2.57

157.13

3.4

3.7

—

Other and unspecified disorders of skin and subcutaneous tissue

192

222

9.24

153.92

4.6

3.8

—

All chronic kidney diseases

742

2018

2.98

152.39

3.9

3.7

—

Donors of organs and tissues

34.52

151.99

3.6

4.9

—

Diffuse large B-cell lymphoma

152

130

12.59

151.07

4.9

2.7

—

Diffuse large B-cell lymphoma, helper endpoint

152

130

12.59

151.07

4.9

2.7

—

Diffuse large B-cell lymphoma, including Hilmo

152

130

12.59

151.07

4.9

2.7

—

Any reimbursement code in KELA

457

510

4.53

143.58

3.9

2.0

—

Solid cancers

796

1633

2.89

142.32

3.4

2.4

—

Solid cancers, including Hilmo

812

1673

2.85

142.26

3.4

2.4

—

Polyarthropathies

806

1882

2.78

138.73

3.5

3.7

—

Covid-19 confirmed case

559

1793

3.17

135.27

4.4

3.6

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

334

729

4.54

134.62

2.4

2.5

—

Persons encountering health services for specific procedures and health care

1114

2831

2.34

132.78

3.6

3.5

—

Myelodysplastic syndrome

40.60

131.99

12.7

3.4

—

Implicit viral Sepsis

330

754

4.48

131.97

5.0

3.5

—

Viral Sepsis

330

757

4.47

131.30

5.0

3.5

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

284

588

5.00

128.64

4.8

4.1

—

Acute tubulo-interstitial nephritis

745

2383

2.67

127.54

3.4

3.5

—

L04AD Calcineurin inhibitors

232

407

5.94

126.65

7.0

3.9

—

Dental caries

377

916

3.96

126.17

5.0

3.4

—

Streptococcal septicaemia, including avohilmo

180

249

7.51

123.51

3.9

3.6

—

Streptococcal septicaemia

179

247

7.53

123.12

3.9

3.6

—

Enlarged lymph nodes

250

483

5.31

122.30

4.6

3.3

—

Caries of dentine

344

822

4.12

122.19

4.7

3.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

107

15.66

120.03

4.3

3.1

—

Multiple myeloma

107

15.66

120.03

4.3

3.1

—

Acute renal failure

378

1027

3.78

119.51

4.4

3.8

—

Implicit viral Sepsis, including avohilmo

407

1176

3.52

116.44

4.6

3.4

—

Other disorders of white blood cells

151

184

8.73

116.06

8.2

3.5

—

Neoplasms

666

1218

2.89

115.49

4.5

2.3

—

Autoimmune diseases

1095

2488

2.25

114.49

3.4

3.7

—

Certain infectious and parasitic diseases, including avohilmo

612

1016

3.04

113.57

4.3

2.7

—

Asthma, unspecified (mode), excluding more controls

460

1006

3.30

109.66

3.4

2.9

—

Other pulmonary diagnosis

651

1148

2.86

109.30

4.4

2.9

—

Explicit bacterial Sepsis

197

342

5.95

108.49

4.5

3.9

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

698

2767

2.50

108.25

4.7

3.4

—

L01XX Other antineoplastic agents

165

242

7.26

108.10

11.0

3.9

—

Other and unspecified disorders of white blood cells

126

134

10.12

107.87

9.0

3.5

—

Multiple myeloma and malignant plasma cell neoplasms

153

208

7.91

107.53

5.0

4.5

—

Explicit bacterial Sepsis, including avohilmo

198

349

5.86

107.30

4.4

4.0

—

Chronic kidney disease

478

1540

3.04

106.86

4.3

3.7

—

Purpura and other haemorrhagic conditions

252

554

4.70

106.19

6.7

3.9

—

Excluding asthma or asthma-COPD overlap

641

1148

2.82

104.80

4.3

2.9

—

Other bacterial intestinal infections

297

752

4.05

103.84

4.7

4.1

—

Asthma, unspecified (mode)

474

1105

3.12

103.72

3.4

2.9

—

Hernia of abdominal wall, postoperative

184

308

6.02

103.69

3.6

2.9

—

Continuous positive airway pressure

291

581

4.27

103.38

3.1

3.6

—

Iron deficiency anaemia

562

2055

2.72

103.20

4.4

3.5

—

Provisional assignment of new diseases of uncertain etiology

635

2500

2.55

102.67

4.3

3.4

—

Thrombocytopenia, unspecified

175

287

6.40

102.64

7.5

3.7

—

Codes for special purposes

635

2504

2.55

102.30

4.3

3.4

—

Drug-induced neutropenia

169

269

6.61

102.15

4.8

4.0

—

Systemic connective tissue disorders

466

1588

2.99

101.88

3.3

3.7

—

Enterocolitis due to Clostridium difficile

215

431

5.17

101.29

5.3

4.0

—

Sulfasalazine

315

845

3.79

101.10

2.8

3.7

—

Fitting and adjustment of other devices

487

1481

2.94

100.77

3.6

3.9

—

Nutritional anaemias

627

2372

2.55

100.76

4.3

3.5

—

Budesonide

197

366

5.51

100.70

3.0

3.8

—

6-mercaptopurine

13.78

100.53

5.1

3.0

—

Bacterial intestinal infections, IBD co-morbidities

296

770

3.94

99.68

4.8

4.0

—

COPD (mode)

345

739

3.69

99.45

3.1

—

Viral pneumonia

207

407

5.22

99.45

4.9

3.7

—

Used for control exclusion in common control thyroid runs

999

2305

2.20

99.14

3.7

3.6

—

Oedema, not elsewhere classified

391

1194

3.25

98.39

3.7

3.4

—

ILD differential diagnosis

632

1174

2.72

96.88

4.4

2.9

—

COPD differential diagnosis

632

1176

2.71

96.59

4.4

2.9

—

Care involving dialysis

168

283

6.19

95.78

3.4

4.7

—

Failure and rejection of transplanted organs and tissues

17.11

95.05

15.2

3.9

—

Coagulation defects, purpura and other haemorrhagic conditions

298

817

3.73

93.02

6.2

3.8

—

Dialysis, with operation codes

220

496

4.58

89.93

4.3

3.9

—

Biological medication for rheuma

243

593

4.19

89.29

2.7

4.0

—

Osteopathies and chondropathies

639

2475

2.39

88.26

3.8

3.7

—

Secondary hypertension

149

239

6.35

87.19

3.5

3.7

—

Other bacterial intestinal infections, including avohilmo

324

978

3.38

87.14

4.5

3.9

—

5-aminosalicylic acid

237

578

4.17

87.00

3.3

3.8

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

230

561

4.18

84.57

2.4

2.5

—

Lung cancer and mesothelioma

242

506

4.13

83.38

3.2

3.4

—

Rheumatoid arthritis

391

1187

2.96

82.14

3.2

3.7

—

Other diseases of pleura

567

2040

2.45

81.82

4.3

3.7

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

276

620

3.72

81.77

3.5

2.5

—

Polycythaemia vera

12.06

80.84

9.7

3.2

—

Tumor necrosis factor alpha inhibitors

213

519

4.19

78.49

2.7

4.0

—

Other and unspecified iron deficiency

428

1602

2.71

78.19

4.0

3.5

—

Nephropathy related operations

208

501

4.28

78.15

4.4

4.2

—

Nausea and vomiting

345

1144

2.98

75.36

3.9

3.6

—

IBD patients in KELA-register

275

821

3.41

75.29

3.2

4.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

251

566

3.74

75.09

3.2

2.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

710

2996

2.13

74.97

3.4

—

Noninfective enteritis and colitis

516

2156

2.42

74.84

3.6

3.7

—

Seropositive rheumatoid arthritis

306

973

3.18

74.80

3.2

3.8

—

Heart failure,strict

568

1686

2.38

73.35

4.4

3.7

—

Other systemic involvement of connective tissue (FG)

308

984

3.12

72.78

3.1

3.7

—

Inflammatory bowel disease

360

1287

2.84

72.19

3.3

4.0

—

Inflammatory bowel disease, strict (require KELA)

275

844

3.31

72.05

3.2

4.0

—

Crohn disease

181

420

4.41

71.23

3.0

4.4

—

Asthma, excluding more controls

515

1043

2.55

70.95

3.2

2.8

—

Extracorporeal dialysis

135

247

5.73

70.81

3.3

4.2

—

Osteoporosis

349

1129

2.89

70.74

3.8

3.9

—

Early onset COPD, excluding more controls

212

566

3.80

68.60

3.2

3.1

—

Other symptoms and signs involving the digestive system and abdomen

230

655

3.58

67.91

3.8

3.9

—

Other disorders of fluid, electrolyte and acid-base balance

407

1497

2.60

67.80

3.4

3.8

—

Persons encountering health services in other circumstances

450

1830

2.46

67.80

3.4

3.6

—

Fentanyl

159

349

4.66

66.96

4.2

4.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

597

2780

2.16

66.67

3.9

3.6

—

Asthma

534

1142

2.43

66.65

3.2

2.9

—

Methotrexate

166

380

4.45

66.42

3.3

4.0

—

Preparatory care for dialysis

110

178

6.54

65.67

3.3

4.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

148

195

5.43

65.17

4.9

3.9

—

Asthma (only as main-diagnosis), excluding more controls

472

1043

2.52

64.94

3.4

2.8

—

ILD, hospital admission 2, with pulmonary infections

144

300

4.93

64.85

5.1

3.5

—

Symptoms and signs involving the urinary system

765

2924

1.99

64.81

3.8

3.7

—

Malignant neoplasm of bronchus and lung, including Hilmo

237

574

3.50

64.52

3.2

2.5

—

Acute upper respiratory infections of multiple and unspecified sites

715

2582

2.03

64.14

4.3

3.3

—

Finngen Rheumatological endpoints

810

2339

1.98

63.46

3.6

—

Acute lymphocytic leukaemia, helper endpoint

29.21

63.36

11.6

3.0

—

Acute lymphocytic leukaemia, including Hilmo

29.21

63.36

11.6

3.0

—

Acute lymphocytic leukaemia

29.21

63.36

11.6

3.0

—

Malignant neoplasm of bronchus and lung

218

510

3.63

62.83

2.8

2.5

—

Follow-up care involving plastic surgery

103

8.44

62.74

2.4

3.8

—

Asthma (only as main-diagnosis)

489

1142

2.41

61.64

3.3

2.9

—

Mental and behavioural disorders due to tobacco

143

310

4.75

61.51

2.3

4.4

—

Smoking dependency

143

312

4.72

61.03

2.3

4.4

—

Substance use, excluding alcohol

230

703

3.32

60.77

2.3

4.0

—

Parasetamol

557

1246

2.27

60.08

3.4

3.6

—

Other viral diseases

313

1143

2.76

59.90

5.9

3.4

—

Hypothyroidism (congenital or acquired)

167

196

4.81

59.30

3.7

1.5

—

Drug-induced cataract

9.37

58.96

5.0

4.1

—

DVT of lower extremities and pulmonary embolism

462

2040

2.28

58.74

4.3

3.7

—

Infections of the skin and subcutaneous tissue

585

2797

2.07

58.67

4.0

3.6

—

Rheumatoid arthritis, including avohilmo

407

1715

2.40

58.36

3.2

3.7

—

Other systemic involvement of connective tissue

319

1201

2.70

58.08

3.2

3.9

—

Cytomegalovirus infection, IBD co-morbidity

9.63

57.03

10.2

4.0

—

Hypothyroidism and >3 levothyroxin purchases

162

194

4.71

56.41

3.7

1.5

—

Hypothyroidism, levothyroxine purchases

162

194

4.71

56.41

3.7

1.5

—

Crohn's disease NAS

111

209

5.49

56.28

2.9

4.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

301

1123

2.72

55.86

3.2

4.0

—

Other/unspecified seropositive rheumatoid arthritis

304

1145

2.70

55.37

3.2

3.9

—

Gastrointestinal diseases

443

918

2.43

55.30

4.2

2.9

—

Other necrotizing vasculopathies (FG)

106

195

5.63

55.17

3.0

4.3

—

Seropositive rheumatoid arthritis, wide

306

1159

2.68

55.11

3.2

3.9

—

Mycoses

320

1241

2.61

54.91

4.7

3.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

258

396

3.29

54.55

4.3

2.4

—

Glomerular disorders in diseases classified elsewhere

169

456

3.80

54.32

3.3

4.4

—

Cytomegaloviral disease

8.90

53.76

10.2

3.6

—

Heart failure, strict

618

2147

2.02

53.73

4.3

3.7

—

Cytomegaloviral disease, including avohilmo

8.71

53.62

10.1

3.5

—

Other/unspecified cytomegaloviral diseases

9.52

53.00

10.7

3.8

—

Mantle cell lymphoma, including Hilmo

17.67

52.70

5.8

3.6

—

Unspecified urinary incontinence

136

321

4.35

52.58

3.0

4.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

213

682

3.18

52.30

4.9

4.1

—

All-cause Heart Failure

607

2126

2.00

51.75

4.3

3.7

—

Glomerular diseases

227

759

3.05

51.74

3.5

4.1

—

Other viral diseases, including avohilmo

361

1505

2.40

51.72

5.6

3.4

—

Later onset COPD, excluding more controls

220

528

3.22

51.57

3.0

3.4

—

Other (seronegative) rheumatoid arthritis, wide

227

763

3.03

51.24

3.3

4.0

—

Presence of other devices

289

1085

2.66

51.12

3.7

3.6

—

Non-small cell lung cancer, including Hilmo

169

440

3.66

51.07

3.0

2.5

—

Venous thromboembolism

544

2610

2.02

50.90

4.4

3.6

—

ILD, hospital admissions 3, with pneumonia sepsis

128

296

4.44

50.82

5.3

3.5

—

Certain disorders involving the immune mechanism

229

778

3.00

50.73

5.7

3.9

—

Viral infections characterized by skin and mucous membrane lesions

429

1964

2.20

50.47

4.7

3.5

—

Anaemia in chronic diseases classified elsewhere

8.34

50.36

3.7

4.4

—

Asthma (mode)

489

1174

2.20

49.60

3.3

2.9

—

Other functional intestinal disorders

467

2011

2.13

49.46

3.6

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

165

5.85

49.43

6.6

4.6

—

Diseases of the skin and subcutaneous tissue

817

2255

1.83

49.33

4.5

3.2

—

Ulcerative colitis, NAS

165

469

3.58

49.01

3.4

4.4

—

Cellulitis

256

941

2.76

48.96

4.1

3.9

—

Other necrotizing vasculopathies

124

289

4.43

48.88

3.2

4.2

—

Chronic laryngitis and laryngotracheitis

184

564

3.33

48.61

2.7

4.2

—

Other problems related to primary support group, including family circumstances

147

376

3.88

48.59

4.6

3.2

—

Fungal Sepsis

131

6.43

48.24

5.8

4.5

—

Mantle cell lymphoma

20.59

47.16

5.9

3.7

—

Diseases of the respiratory system

457

1038

2.22

46.72

4.2

2.9

—

Headache

479

1787

2.08

46.67

3.6

3.0

—

Essential (haemorrhagic) thrombocythaemia

8.01

46.59

7.2

2.7

—

Diseases of liver

365

1621

2.28

46.48

3.1

3.9

—

Leukaemia of unspecified cell type

13.39

46.34

8.5

5.0

—

Disorders of other endocrine glands

430

2015

2.12

45.76

3.7

3.6

—

Adalimumab

125

309

4.13

45.42

2.5

4.1

—

Malignant neoplasm of digestive organs, including Hilmo

346

1085

2.36

45.19

2.8

2.4

—

Other diseases of intestines

865

2794

1.73

45.02

3.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

326

1184

2.39

44.93

3.4

4.1

—

Immunodeficiency with predominantly antibody defects

7.64

44.92

6.8

3.7

—

Ulcerative colitis

251

956

2.66

44.77

3.4

4.2

—

Acute bronchitis

421

1972

2.11

44.45

4.2

3.5

—

Other acute lower respiratory infections

524

2575

1.95

44.31

4.4

3.4

—

Kidney transplant status

210

4.90

43.97

4.3

4.4

—

Orthopaedic devices associated with adverse incidents

8.81

43.79

2.6

3.8

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

101

219

4.74

43.52

2.8

4.5

—

Disorders of gallbladder, biliary tract and pancreas

851

3112

1.71

43.35

3.7

—

Marginal zone B-cell lymphoma, including Hilmo

14.81

42.85

6.6

4.4

—

COPD, hospital admission 2, with asthma infections

367

1438

2.22

42.85

3.3

4.0

—

L01XE Protein kinase inhibitors

100

220

4.73

42.55

13.7

4.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

320

1397

2.32

42.49

3.7

3.9

—

Non-invasive ventilation

227

717

2.76

42.29

4.1

3.6

—

Other/unspecified rheumatoid arthritis

159

490

3.31

41.76

3.6

4.1

—

Type of accident

301

1291

2.36

41.66

3.6

3.9

—

Implicit fungal Sepsis

117

6.30

41.52

6.2

4.8

—

Implicit fungal Sepsis, including avohilmo

101

228

4.54

41.41

5.2

4.2

—

Other reaction to severe stress, and adjustment disorders

307

1330

2.33

41.33

4.2

3.5

—

Polyneuropathies and other disorders of the peripheral nervous system

255

1024

2.53

40.93

4.9

3.9

—

Malignant neoplasm of digestive organs

314

1031

2.35

40.87

2.7

2.4

—

Gout

307

1135

2.35

40.81

4.2

4.1

—

Ulcer of lower limb, not elsewhere classified

186

638

2.97

40.66

3.7

4.1

—

All influenza (not pneumonia)

149

448

3.37

40.58

5.4

3.6

—

Non-small cell lung cancer

120

309

3.91

40.43

2.3

2.6

—

Crohn disease (strict definition, require KELA, min 2 HDR)

205

4.71

40.26

2.9

4.5

—

Crohn disease (strict definition, require KELA)

206

4.69

40.01

2.9

4.5

—

Other noninfective gastroenteritis and colitis

260

1063

2.47

40.01

4.0

4.2

—

Other specific joint derangements/joint disorders

595

2008

1.86

39.96

3.2

3.6

—

Factors influencing health status and contact with health services

213

356

3.02

39.73

4.9

3.0

—

Acute sinusitis

426

1928

2.02

39.62

4.8

3.2

—

Moderate visual impairment, binocular

123

6.05

39.60

3.1

3.9

—

Other dialysis

120

6.14

39.52

3.8

5.0

—

Crohn's disease of large intestine

153

5.32

38.91

3.5

4.0

—

Zoster [herpes zoster]

221

850

2.64

38.82

5.3

4.0

—

Malignant neoplasm of skin, including Hilmo

385

1221

2.13

38.42

4.6

2.4

—

Depression medications

156

216

3.65

38.41

3.1

1.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

136

401

3.47

38.40

9.5

3.7

—

Other disorders of lacrimal gland

355

1692

2.12

37.97

4.2

3.6

—

Crohn's disease of small intestine

211

4.51

37.91

2.6

4.6

—

Pulmonary heart disease, diseases of pulmonary circulation

332

1547

2.17

37.67

4.6

3.8

—

Other chronic obstructive pulmonary disease

455

1922

1.96

37.62

3.2

3.9

—

Seronegative rheumatoid arthritis

133

393

3.44

37.35

3.2

4.1

—

Acquired haemolytic anaemia

7.16

37.26

6.7

4.5

—

Gout, FINNGEN

307

1384

2.23

37.20

4.2

4.0

—

Dialysis

156

5.21

37.19

4.4

4.7

—

Pain in joint

493

1578

1.93

37.17

3.3

3.6

—

Symptoms and signs involving the digestive system and abdomen

813

2435

1.68

37.15

3.7

3.6

—

COPD

465

1973

1.93

37.04

3.1

3.9

—

Malignant neoplasm of skin

370

1187

2.12

36.95

4.6

2.4

—

Pulmonary heart disease

307

1402

2.21

36.67

4.5

3.8

—

Pulmonary embolism

307

1403

2.21

36.60

4.5

3.8

—

Hypothyroidism, drug reimbursement

115

5.20

36.29

3.2

1.3

—

Unspecified kidney failure

142

447

3.24

36.10

4.6

3.7

—

Asthma, hospital admissions 3, pneumonia

381

1896

2.02

35.92

3.6

3.8

—

Asthma-related pneumonia or sepsis

381

1896

2.02

35.92

3.6

3.8

—

COPD, early/later onset

460

2037

1.91

35.82

3.2

3.9

—

Respiratory insufficiency

212

4.36

35.65

3.2

3.4

—

Asthma-related pneumonia

379

1894

2.01

35.33

3.6

3.8

—

Ulcerative colitis (strict definition, require KELA)

168

589

2.89

35.29

3.4

3.8

—

Other Crohn's disease

211

4.36

35.20

2.7

4.2

—

Syncope and collapse

361

1468

2.07

35.17

3.6

3.3

—

COPD, hospital admissions

454

2028

1.90

34.86

3.2

3.9

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

163

566

2.92

34.85

3.4

3.9

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

176

640

2.79

34.53

3.4

4.0

—

SLE (Finngen)

6.48

34.40

3.5

4.2

—

DVT of lower extremities

207

819

2.56

34.36

4.2

3.9

—

Other arthritis (FG)

275

1234

2.25

34.29

3.8

3.7

—

Undetermined asthma, excluding more controls

114

323

3.57

34.05

3.4

3.0

—

Visual impairment including blindness (binocular or monocular)

104

279

3.82

33.91

3.1

4.1

—

Cardiovascular diseases

416

1107

2.00

33.70

3.8

3.0

—

Other and unspecified polyneuropathies, also in other diseases

217

887

2.48

33.66

4.6

4.0

—

Disorders resulting from impaired renal tubular function

147

5.10

33.57

3.5

4.3

—

Other chronic obstructive pulmonary disease, including avohilmo

518

2376

1.80

33.53

3.1

3.9

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

227

935

2.42

33.50

4.7

3.3

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

174

4.64

33.44

2.8

2.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

308

1462

2.13

33.39

4.4

3.6

—

Non-ischemic cardiomyopathy

342

1319

2.08

33.32

4.8

3.7

—

Obesity due to excess calories

400

2085

1.93

33.32

2.9

3.7

—

Symptoms and signs concerning food and fluid intake

115

335

3.48

32.93

3.2

3.4

—

Immunodeficiencies

185

4.53

32.91

6.3

3.8

—

Undetermined asthma

114

331

3.48

32.82

3.4

3.0

—

Other respiratory diseases principally affecting the interstitium

208

846

2.50

32.63

4.6

4.0

—

Disorders of mineral metabolism

114

334

3.49

32.57

3.8

4.4

—

COPD related to multimorbidity

403

1778

1.93

32.53

3.2

4.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

212

576

2.56

32.49

3.4

3.5

—

therapeutic use

115

5.63

32.20

2.6

3.9

—

Crohn disease (strict definition, all UC cases excluded)

160

4.75

32.10

2.8

4.1

—

Hypothyroidism, strict autoimmune

528

1948

1.79

31.93

3.2

3.7

—

Candidiasis

157

561

2.84

31.92

3.6

3.9

—

Pleural effusion

182

702

2.63

31.92

4.1

3.9

—

Special screening examination for infectious and parasitic diseases

155

383

2.97

31.86

2.1

3.3

—

Hypo-osmolality and hyponatraemia

203

820

2.49

31.71

3.6

4.1

—

Other respiratory disorders and diseases

228

979

2.36

31.70

3.9

4.1

—

Other diseases of the respiratory system

228

979

2.36

31.70

3.9

4.1

—

Substance abuse, excluding more controls

477

2214

1.81

31.54

2.5

3.8

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

128

5.22

31.46

5.3

2.6

—

Viral pneumonia (unknown virus, not influenza)

239

3.94

31.41

5.5

4.4

—

Disorders of calcium metabolism

253

3.85

31.35

3.5

4.3

—

Diagnoses used for exclusion with ILD

254

1151

2.23

31.05

4.2

4.0

—

Other pleural conditions

137

463

3.02

30.93

5.7

3.8

—

Other viral diseases, not elsewhere classified

182

712

2.58

30.72

5.7

3.6

—

SLE, strict definition

102

5.79

30.70

3.5

—

SLE, ICD10

102

5.79

30.70

3.5

—

Convulsions, not elsewhere classified

185

722

2.55

30.65

3.4

3.1

—

Malignant neoplasm of breast, HER2-negative

265

763

2.25

30.41

2.5

2.3

—

Malignant neoplasm of breast

265

763

2.25

30.40

2.5

2.3

—

COPD-related respiratory insufficiency

146

516

2.88

30.39

3.8

4.3

—

Haemolytic anaemias

125

5.23

30.34

6.4

4.2

—

Acute pharyngitis

136

459

2.97

30.02

4.4

3.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

337

1129

2.03

29.90

4.7

2.4

—

Secondary malignant neoplasm of other and unspecified sites

9.44

29.71

2.4

3.3

—

Osteoporosis with pathological fracture (FG)

258

3.72

29.68

2.9

3.9

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

268

778

2.22

29.65

2.5

2.3

—

Malignant neoplasm of breast, including Hilmo

268

778

2.22

29.64

2.5

2.3

—

Heart failure and bmi 25plus

399

1413

1.90

29.30

4.2

3.5

—

Other diseases of blood and blood-forming organs

252

3.74

29.16

6.6

3.4

—

Systemic lupus erythematosus

107

5.51

29.16

3.5

3.6

—

Dental operations

490

1402

1.81

29.09

4.4

3.4

—

Other autoimmune haemolytic anaemias

8.17

28.89

5.4

4.1

—

Basal cell carcinoma, including Hilmo

327

1106

2.01

28.60

4.6

2.4

—

ILD, hospital admissions

176

707

2.53

28.46

4.8

4.0

—

Interstitial lung disease

178

720

2.51

28.36

4.8

4.0

—

Interstitial lung disease endpoints

178

720

2.51

28.36

4.8

4.0

—

Other interstitial pulmonary diseases

178

720

2.51

28.36

4.8

4.0

—

Polymyalgia rheumatica

157

598

2.67

28.33

3.3

4.4

—

Generalized skin eruption due to drugs and medicaments

153

4.60

28.21

4.1

4.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

221

985

2.27

28.20

3.7

3.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

324

1102

2.01

28.11

4.7

2.4

—

Other specified/unspecified arthritis

236

1083

2.20

27.98

3.8

3.7

—

Paralytic ileus and intestinal obstruction

251

1180

2.15

27.95

3.7

3.8

—

Dermatitis due to substances taken internally

196

4.08

27.95

4.4

4.8

—

Secondary malignant neoplasm of respiratory and digestive organs

9.36

27.91

1.4

3.0

—

Diseases of external ear

332

1730

1.94

27.85

3.3

3.7

—

Malignant neoplasm of eye, brain and central nervous system

5.59

27.80

3.8

2.7

—

Other viral diseases, not elsewhere classified, including avohilmo

226

1020

2.22

27.45

5.1

3.5

—

Neurological diseases, wide definition

189

367

2.60

27.33

3.8

3.0

—

Drug-induced osteoporosis

8.89

27.32

4.1

3.5

—

Exclusions for E4_PCOS_BROAD

172

697

2.50

27.20

4.2

4.0

—

Drug-induced osteoporosis with pathological fracture

7.25

27.04

3.3

3.6

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

5.56

27.04

2.5

—

Basal cell carcinoma

313

1073

2.00

26.97

4.7

2.4

—

Other nutritional deficiencies

523

2864

1.68

26.83

2.9

3.6

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

508

2361

1.70

26.63

3.0

4.0

—

Acute generalized exanthematous pustulosis

173

4.23

26.58

4.2

4.1

—

Asthma-related infections

511

2986

1.68

26.55

3.4

3.6

—

Asthma, hospital admission 2, infections

511

2986

1.68

26.55

3.4

3.6

—

Non-small cell lung cancer, adenocarcinoma

165

4.27

26.38

2.2

2.7

—

Myalgia

209

937

2.25

26.28

2.9

3.7

—

Other abnormal uterine and vaginal bleeding

199

610

2.37

26.17

3.5

3.2

—

Nonhereditary hypogammaglobulinemia

9.11

26.11

7.2

3.6

—

Pyogenic arthritis

215

3.79

26.07

2.8

4.6

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

159

635

2.54

26.06

3.6

4.3

—

Phlebitis and thrombophlebitis (not including DVT)

213

968

2.22

25.96

3.7

—

Early onset COPD

212

963

2.23

25.89

3.2

4.0

—

Chronic gastritis

255

1244

2.07

25.87

4.4

3.7

—

Candidiasis, including avohilmo

261

1286

2.05

25.74

3.4

3.5

—

Abdominal and pelvic pain

753

2435

1.56

25.74

3.7

3.6

—

Systemic lupus erythematosus, unspecified

5.64

25.71

3.3

3.7

—

Gonarthrosis [arthrosis of knee](FG)

554

1922

1.67

25.56

3.3

3.8

—

Fibrosis and cirrhosis of liver

100

316

3.23

25.44

3.4

4.1

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

170

4.13

25.34

3.7

2.6

—

Arthropathies in other diseases classified elsewhere

114

4.97

25.19

4.1

3.9

—

Small cell lung cancer, including Hilmo

7.11

25.14

1.8

3.0

—

Small cell lung cancer

7.11

25.14

1.8

3.0

—

Hypokalaemia

137

518

2.68

25.13

3.2

4.3

—

Substance abuse

477

2647

1.68

24.97

2.5

3.9

—

Valvular heart disease excluding rheumatic fever

402

1614

1.79

24.97

4.0

3.9

—

Bacterial pneumoniae

296

1343

1.95

24.87

3.9

3.4

—

Malignant neoplasm of breast, HER-positive

209

696

2.25

24.86

2.4

—

Disorders of thyroid, IBD co-morbidities

117

264

3.05

24.86

3.6

3.3

—

Intestinal stricture

297

1551

1.93

24.84

3.5

4.0

—

Diseases of the digestive system

420

2417

1.74

24.84

3.8

3.7

—

Malignant neoplasm of breast, ER-positive, including Hilmo

209

696

2.25

24.79

2.4

—

Obesity

487

2760

1.67

24.78

2.7

3.6

—

Other skin changes

198

892

2.25

24.71

5.3

3.8

—

Other and unspecified aplastic anaemias

8.77

24.68

5.8

4.0

—

Cutaneous abscess, furuncle and carbuncle

227

1080

2.12

24.63

3.6

3.8

—

L04AC Interleukin inhibitors

210

3.74

24.60

2.3

4.3

—

Obesity and other hyperalimentation

488

2773

1.66

24.45

2.7

3.6

—

Non-rheumatic valve diseases

397

1597

1.78

24.45

4.0

3.8

—

Zoster [herpes zoster], including avohilmo

447

2555

1.70

24.35

4.7

3.5

—

Diverticular disease of intestine

557

2131

1.63

24.32

4.1

3.6

—

COPD, hospital admissions 1, only main diagnosis

333

1551

1.86

24.22

3.2

3.9

—

Unspecified haematuria

384

1765

1.78

24.17

4.0

3.8

—

Gout, unspecified

218

1031

2.14

24.12

4.3

4.0

—

Seropositive rheumatoid arthritis, strict definition

150

605

2.51

24.11

2.9

3.8

—

Mature T/NK-cell lymphomas, hilmo

7.18

24.10

8.4

3.7

—

Infliximab

6.80

23.99

2.2

2.9

—

ILD, hospital admissions 1, main diag only

156

643

2.46

23.97

4.8

4.0

—

Mental and behavioural disorders due to psychoactive substance use

484

2686

1.66

23.96

2.6

3.9

—

Diseases of the myoneural junction and muscle

137

531

2.62

23.95

3.4

4.4

—

Familial hypercholesterolemia

166

705

2.39

23.84

3.7

4.3

—

Collagenous colitis

105

355

3.01

23.79

3.7

4.2

—

FESS (DNB20)

120

436

2.79

23.78

3.9

4.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

128

481

2.69

23.74

3.6

4.0

—

Presence of cardiac and vascular implants and grafts

382

1584

1.79

23.69

3.0

3.6

—

Idiopathic thrombocytopenic purpura

113

4.86

23.54

6.3

3.9

—

Malignant neoplasm of other connective and soft tissue

6.82

23.52

2.6

3.1

—

Insulin medication

511

2607

1.63

23.51

3.6

3.8

—

Noninfectious colitis NAS

134

518

2.62

23.51

3.9

4.4

—

Vocal cord dysfunction

108

323

2.97

23.41

3.0

3.7

—

Diseases of peritoneum

111

391

2.89

23.36

3.4

3.9

—

Malignant neoplasm of brain, including Hilmo

114

4.74

23.17

3.8

2.5

—

Malignant neoplasm of mesothelium and soft tissue

5.07

23.09

2.6

2.8

—

Viral pneumonia (known virus, not influenza)

115

4.78

23.07

6.5

5.0

—

Leisure time condition

170

743

2.31

22.84

3.4

4.2

—

Malignant neoplasm of brain

5.91

22.82

4.2

2.9

—

Misadventures to patients during surgical and medical care

139

556

2.53

22.75

3.5

3.6

—

Acute suppurative otitis media

195

844

2.17

22.24

3.8

3.2

—

Amputation

123

471

2.65

22.08

3.2

4.2

—

Cholangitis (primary sclerosing, PSC)

247

3.35

21.90

3.4

4.0

—

Polyarthrosis

188

780

2.19

21.79

2.8

3.9

—

Chronic ulcer of skin, not elsewhere classified

285

3.15

21.55

5.7

3.7

—

Other joint disorders

623

2095

1.56

21.48

3.3

3.6

—

Molar incisor enamel hypoplasia, with caries

7.34

21.44

7.5

2.8

—

Pain, not elsewhere classified

195

924

2.12

21.42

3.8

3.2

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

8.12

21.41

3.9

3.1

—

Disorders of parathyroid gland

191

888

2.15

21.41

3.7

3.8

—

Anxiety disorders, excluding more controls

601

2483

1.55

21.36

3.6

—

Retention of urine

315

1408

1.82

21.33

3.5

3.8

—

malignant neoplasm of male genital organs, including Hilmo

213

603

2.14

21.28

4.0

2.5

—

malignant neoplasm of male genital organs

211

597

2.14

21.26

3.7

2.5

—

Coxarthrosis [arthrosis of hip](FG)

418

1710

1.69

21.25

3.9

—

Other specified/unspecified systemic involvement of connective tissue

189

3.67

21.20

2.7

4.0

—

Ethmoidectomy

120

463

2.62

21.20

3.9

4.2

—

Other diseases of the digestive system

298

1642

1.83

21.16

3.9

—

Other cataract

357

1521

1.75

21.03

3.8

3.7

—

Gout, idiopatic and unspecified

249

1304

1.93

20.80

4.2

4.0

—

Hypoplasia of dental enamel

6.15

20.74

6.3

4.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

511

2952

1.58

20.67

3.6

3.7

—

Follicular lymphoma, hilmo

165

3.87

20.66

4.7

4.5

—

Volume depletion

112

424

2.68

20.60

2.9

4.4

—

Stomatitis and related lesions

178

828

2.17

20.59

5.6

3.9

—

Convalescence

156

3.92

20.58

2.8

3.6

—

Mucosal proctocolitis

110

413

2.69

20.51

3.1

4.2

—

Hypercalcemia

175

3.76

20.51

4.0

4.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

188

883

2.12

20.42

2.7

3.6

—

Haemorrhage from respiratory passages

303

1494

1.81

20.33

4.8

3.3

—

Eosinophilic disease (BM)

8.26

20.16

5.2

3.2

—

Obesity related asthma

294

1638

1.81

20.15

3.2

3.9

—

External causes of morbidity and mortality

435

1305

1.68

20.11

3.8

3.5

—

Infections with a predominantly sexual mode of transmission

200

981

2.05

19.95

2.9

3.4

—

Unspecified fall

435

2651

1.62

19.87

3.2

3.7

—

Hyperkalaemia

263

3.15

19.80

4.1

4.6

—

Other or unspecified ileus, impaction or obstruction

175

823

2.15

19.70

3.7

4.0

—

Malignant neoplasm of prostate

203

573

2.11

19.67

3.5

2.5

—

Gastroduodenal ulcer

237

1240

1.92

19.65

3.2

3.7

—

Hydronephrosis

111

429

2.62

19.59

2.9

3.9

—

Other condition

131

548

2.42

19.54

3.9

—

Impacted cerumen

128

531

2.45

19.50

2.6

4.2

—

Malignant neoplasm of colon, including Hilmo

135

572

2.37

19.32

2.6

2.5

—

Spondyloarthritis

142

618

2.32

19.32

2.6

4.2

—

Diseases of arteries, arterioles and capillaries

553

2651

1.54

19.32

3.6

3.8

—

Other and unspecified myopathies

101

376

2.73

19.25

3.9

4.0

—

Gout, strict definition

186

905

2.08

19.23

4.3

3.9

—

Aspergillosis

7.30

19.01

11.3

3.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

334

2.83

19.00

3.3

3.9

—

Arthropathies

630

2114

1.51

18.97

3.4

3.6

—

Secondary thrombocytopenia

7.12

18.90

4.3

3.4

—

Gastric ulcer

166

780

2.15

18.78

3.4

4.0

—

Hepatic failure, not elsewhere classified

149

3.87

18.69

4.6

—

Conjunctivitis (acute, non atopic)

236

1252

1.89

18.69

3.2

3.7

—

Visual disturbances and blindness

428

2688

1.60

18.68

3.8

3.5

—

Aspergillosis, including avohilmo

7.12

18.61

11.3

3.7

—

GI-bleeding

290

1649

1.77

18.59

3.9

—

Diseases of the musculoskeletal system and connective tissue

361

1054

1.72

18.52

4.0

3.4

—

Suppurative and unspecified otitis media

256

1235

1.85

18.51

3.7

3.3

—

Other antidepressants

748

2640

1.45

18.49

3.0

3.8

—

Bacterial pneumonia, not elsewhere classified

263

1269

1.83

18.46

3.9

3.4

—

malignant neoplasm of female genital organs

108

414

2.58

18.42

2.3

2.4

—

Acute peritonitis

259

3.07

18.37

3.6

4.2

—

Pneumonia derived septicemia

133

4.02

18.34

4.1

4.7

—

Colorectal cancer, including Hilmo

179

810

2.07

18.31

2.8

2.4

—

Sicca syndrome [Sjögren]

293

2.91

18.10

3.0

3.4

—

Spondylopathies (FG)

109

434

2.54

18.10

2.3

4.0

—

Malignant neoplasm of bladder, including Hilmo

365

2.68

18.10

3.7

2.5

—

Colorectal cancer

164

745

2.13

18.02

2.8

2.4

—

Epilepsy

260

1442

1.81

17.95

3.5

4.0

—

Malignant immunoproliferative diseases

6.58

17.94

9.1

4.1

—

Any operation in hilmo

20.65

17.94

3.0

1.3

—

Psoriatic and enteropathic arthropathies

100

384

2.63

17.90

2.2

4.1

—

Malignant neoplasm of prostate, including Hilmo

201

585

2.04

17.89

3.7

2.6

—

Speech therapy

1242

0.20

17.88

3.7

4.0

—

Diseases of spleen

5.37

17.86

7.6

4.5

—

Respiratory disorders in diseases classified elsewhere

6.44

17.85

4.3

3.4

—

Poisoning by drugs, medicaments and biological substances

173

842

2.07

17.83

2.9

3.7

—

Pain (limb, back, neck, head abdominally)

519

1679

1.55

17.79

3.9

3.6

—

Rare circulating lymphoid malignancy

26.79

17.76

8.2

4.3

—

Malignant neoplasm of colon

113

462

2.47

17.73

2.6

2.5

—

Other complications of surgical and medical care, not elsewhere classified

352

2.71

17.72

4.7

3.8

—

Hypopituitarism

270

2.97

17.67

3.8

4.7

—

Sarcoidosis

118

496

2.41

17.48

4.2

3.9

—

Spontaneous rupture of synovium and tendon

299

2.85

17.45

3.5

4.2

—

malignant neoplasm of female genital organs, including Hilmo

117

465

2.42

17.41

2.3

2.4

—

Other diseases of biliary tract

350

2.70

17.39

2.8

3.9

—

MS-disease / Multiple Sclerosis

205

3.27

17.36

3.2

3.6

—

Serous carcinoma of ovary, including Hilmo

5.26

17.28

2.3

2.7

—

Diseases of middle ear and mastoid

411

2116

1.59

17.20

4.1

3.4

—

Other infectious diseases

313

2.79

17.17

7.0

3.8

—

Inflammatory diseases of the central nervous system

308

2.80

17.10

4.1

4.3

—

Other disorders of kidney and ureter

128

564

2.30

17.05

4.9

4.1

—

Other follicular disorders

249

3.02

17.02

4.6

4.9

—

Polyarteritis nodosa and related conditions

6.33

17.02

4.7

3.2

—

351

2135

1.64

17.01

3.6

3.7

—

Polyuria

196

1016

1.95

16.98

4.3

3.9

—

Pneumonia due to Streptococcus pneumoniae

118

4.06

16.97

3.4

3.3

—

All anxiety disorders

412

2020

1.59

16.93

3.1

3.5

—

Giant cell arteritis

179

3.44

16.93

2.8

4.3

—

Malignant neoplasm of urinary organs, including Hilmo

315

2.76

16.91

3.7

2.7

—

Malignant neoplasm of bladder

204

3.23

16.79

3.1

2.6

—

Primary biliary cholangitis, wide definition

5.58

16.75

3.3

4.5

—

Malignant neoplasm of ovary, including Hilmo

137

3.78

16.74

2.7

2.6

—

Sequelae of external causes of morbidity and mortality

218

1177

1.87

16.68

4.2

3.9

—

Ulcerative enterocolitis

4.65

16.65

3.8

4.1

—

Other diseases of lip and oral mucosa

329

1999

1.66

16.59

4.0

3.6

—

Cerebrovascular diseases

584

2763

1.47

16.53

3.8

3.7

—

Problems related to lifestyle

336

2.68

16.52

2.7

4.0

—

Decubitus ulcer and pressure area

265

2.92

16.46

4.2

4.0

—

Coxarthrosis

381

1525

1.62

16.40

3.7

3.8

—

Anxiety (asthma-related co-morbidities)

405

1951

1.58

16.40

3.0

3.6

—

Genitourinary diseases

387

1192

1.63

16.37

3.8

3.5

—

Insulin, intermediate and long-acting

440

2769

1.54

16.32

3.3

3.8

—

Gonarthrosis

458

1670

1.56

16.22

3.4

3.8

—

Bipolar affective disorders

132

601

2.21

16.21

2.7

3.6

—

Disorders of optic nerve and visual pathways

346

2.64

16.15

4.2

4.0

—

Internal derangement of knee

264

1508

1.74

16.11

3.3

3.8

—

Other diseases of liver

153

741

2.08

16.08

2.7

3.9

—

Chronic myeloid leukaemia, including Hilmo

13.84

15.96

10.2

3.7

—

Malignant neoplasm of head and neck, including Hilmo

269

2.86

15.95

4.1

2.9

—

Pneumococcal septicemia

133

3.79

15.95

4.1

—

Corticotropin deficiency

7.66

15.88

2.3

4.1

—

Any mental disorder

787

2832

1.40

15.77

3.5

3.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

326

1978

1.63

15.59

4.1

3.6

—

Recurrent aphthous stomatitis , including avohilmo

131

605

2.19

15.59

6.1

3.9

—

Other female pelvic inflammatory diseases

123

554

2.24

15.56

3.7

3.5

—

Wegener granulomatosis

5.96

15.53

3.1

4.2

—

Osteomyelitis

269

2.84

15.45

3.3

4.2

—

Infection due to other mycobacteria

6.89

15.40

7.1

3.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

190

3.20

15.34

2.6

2.7

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

116

513

2.28

15.32

2.8

3.7

—

Suppurative and necrotic conditions of lower respiratory tract

233

2.98

15.24

3.4

4.4

—

Lung transplant status

7.00

15.18

10.9

4.1

—

Lung transplantation

7.00

15.18

10.9

4.1

—

Arthrosis

483

1752

1.52

15.17

3.5

3.7

—

Juvenile arthritis (FINNGEN)

128

3.73

15.17

2.6

4.5

—

Squamous cell neoplasms and carcinomas of the skin

316

2.65

15.17

6.0

2.5

—

Temporal arteritis

157

3.47

15.17

2.7

4.3

—

Nonsuppurative otitis media

169

745

1.98

15.15

4.5

3.3

—

Malignant melanoma, including Hilmo

117

522

2.26

15.14

4.7

2.5

—

Dysphagia

209

1149

1.83

15.14

3.5

3.7

—

Non-small cell lung cancer, squamous

124

3.77

15.06

2.5

2.6

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

401

2.44

15.06

6.6

2.4

—

Non-selective monoamine reuptake inhibitors

282

1619

1.68

15.04

3.3

3.9

—

Other local infections of skin and subcutaneous tissue

401

2.45

14.99

3.8

4.1

—

Sequelae of cerebrovascular disease

320

1684

1.63

14.98

3.8

—

Diseases of pulp and periapical tissues and dental caries

495

1690

1.51

14.95

4.0

3.6

—

Malignant neoplasm of ovary

4.15

14.93

2.7

—

Other diseases of pericardium

184

3.22

14.85

6.4

3.5

—

Ascites

282

2.73

14.68

3.3

4.4

—

Other and unspecified local infections of skin and subcutaneous tissue

375

2.48

14.67

3.7

4.0

—

Infection due to other mycobacteria, including avohilmo

6.51

14.64

7.1

3.1

—

Fracture of lumbar spine and pelvis

198

1080

1.84

14.62

3.7

3.8

—

Charcot foot

4.96

14.61

4.0

5.1

—

Peripheral artery disease

376

1908

1.57

14.59

3.5

3.9

—

Other ulcerative colitis

176

3.23

14.52

3.7

4.2

—

Amputation of toe

313

2.63

14.48

3.0

4.3

—

Giant cell arteritis with polymyalgia rheumatica

162

3.36

14.46

2.7

4.3

—

Peripheral artery operations in Hilmo

126

592

2.15

14.40

2.9

4.1

—

Abnormalities of heart beat

264

1524

1.69

14.39

3.2

—

Etanercept

209

3.01

14.29

3.5

3.7

—

Suicide or other Intentional self-harm

168

880

1.92

14.18

2.7

3.8

—

Spondylopathies in diseases classified elsewhere

5.66

14.16

4.1

3.0

—

Other CVD (FINNGEN)

100

320

2.41

14.12

3.6

3.4

—

Malignant neoplasm of urinary organs

271

2.72

14.07

3.6

2.7

—

Caries of dentine, including avohilmo

581

2067

1.44

14.07

3.8

3.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

188

1024

1.85

14.05

2.7

3.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified

112

508

2.22

13.96

3.0

3.3

—

Poisoning by medicine

146

733

2.01

13.95

2.9

3.7

—

Irritable bowel syndrome

194

1070

1.82

13.93

3.6

—

Menorrhagia

222

687

1.81

13.92

2.9

3.1

—

Total colectomy operation

151

3.38

13.88

2.5

4.1

—

Total colectomy

151

3.38

13.88

2.5

4.1

—

Cystic kidney disease

113

3.81

13.87

4.5

3.8

—

Hodgkin lymphoma, hilmo

104

3.95

13.87

4.4

3.5

—

Heart failure and coronary heart disease

382

1739

1.55

13.82

3.9

3.8

—

Infectious mononucleosis

224

2.89

13.78

4.9

3.5

—

Infectious mononucleosis, including avohilmo

224

2.89

13.78

4.9

3.5

—

Demyelinating diseases of the central nervous system

252

2.77

13.74

3.2

3.6

—

Injuries to the ankle and foot

503

2974

1.45

13.73

3.4

3.5

—

Special screening examination for neoplasms

177

3.14

13.72

2.3

4.2

—

Hyperparathyroidism

154

784

1.96

13.70

3.6

3.7

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

275

2.68

13.69

3.6

2.7

—

Intestinal adhesions without obstruction

334

2.52

13.64

3.5

4.0

—

Gonarthrosis,primary

668

2908

1.39

13.61

3.3

3.8

—

Insulin, fast-acting

277

1697

1.64

13.60

3.4

3.8

—

Other otitis externa (chronic)

244

2.79

13.45

3.3

4.3

—

Ankylosing spondylitis

295

2.61

13.45

2.2

4.3

—

Acquired absence of limb

10.24

13.43

3.2

4.9

—

Malignant melanoma

104

466

2.25

13.38

5.0

2.5

—

Primary Sclerosing Cholangitis, IBD and UDCA required

4.82

13.38

4.5

4.3

—

Paracetamol or NSAID medication

116

257

2.29

13.24

4.7

4.0

—

Acute pancreatitis

161

853

1.90

13.19

4.3

4.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

127

620

2.06

13.13

2.9

3.4

—

Other disorders of patella

116

548

2.13

13.09

3.7

—

Marginal zone B-cell lymphoma

13.68

13.09

6.3

4.3

—

Other retinal disorders

509

2701

1.44

13.07

3.9

3.8

—

Acute posthaemorrhagic anaemia

113

3.70

13.07

6.9

4.1

—

Other disorders of bone

142

724

1.98

13.03

3.6

3.9

—

Other inflammatory liver diseases

232

2.80

12.97

2.7

4.1

—

Other anxiety disorders

294

1566

1.60

12.92

2.8

3.4

—

Psoriasis (vulgaris), strict definition

119

3.61

12.87

2.2

4.2

—

Impingement syndrome of shoulder

184

1026

1.81

12.82

3.4

3.8

—

Viral hepatitis, IBD co-morbidity

3.89

12.79

2.8

3.4

—

Drug-induced polyneuropathy

5.81

12.79

7.9

4.0

—

Otitis externa

178

985

1.82

12.72

3.3

4.0

—

Fibromyalgia

280

2.60

12.70

2.4

3.9

—

Later onset COPD

253

1230

1.66

12.68

3.1

4.0

—

Malignant melanoma of skin, including Hilmo

420

2.28

12.65

4.2

2.6

—

Lack of expected normal physiological development

5.58

12.58

2.1

1.7

—

Other juvenile arthritis

116

3.59

12.57

2.8

4.6

—

Abnormal results of function studies

300

2.53

12.51

4.7

4.0

—

Eosinophilia

4.84

12.47

5.1

3.5

—

Malignant neoplasm of head and neck

226

2.77

12.42

4.0

2.8

—

Dental caries, including avohilmo

535

1924

1.43

12.41

4.1

3.7

—

Malignant neoplasm of kidney, except renal pelvis

249

2.68

12.38

3.5

2.8

—

Injury, poisoning and certain other consequences of external causes

347

1119

1.56

12.29

3.9

3.4

—

Other specified/unspecified bacterial intestinal infections

239

2.72

12.29

3.5

4.3

—

Adrenocortical insufficiency

128

3.43

12.25

3.7

4.0

—

Injuries to the thorax

356

2368

1.51

12.24

3.6

3.9

—

Cirrhosis of liver, NAS

240

2.72

12.22

3.8

4.3

—

Colorectal adenocarcinoma

127

629

2.01

12.19

2.9

2.5

—

Arthropathic psoriasis

402

2.29

12.18

2.1

4.3

—

Rheumatism, unspecified

104

486

2.16

12.13

3.1

3.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

293

2.53

12.12

3.6

4.1

—

Disorders of sclera, cornea, iris and ciliary body

389

2643

1.48

12.10

3.7

3.5

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

151

807

1.89

12.08

3.4

4.3

—

Malignant neoplasm, without specification of site, including Hilmo

124

3.43

12.06

4.5

3.0

—

Ankylosing spondylitis, ICD10

300

2.50

12.02

2.2

4.2

—

Other disorders involving the immune mechanism, not elsewhere classified

120

3.50

12.00

8.9

3.9

—

Small cell lung cancer, helper endpoint

106

3.67

11.96

1.8

4.5

—

Weight loss

444

2.21

11.95

3.4

4.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

345

1790

1.52

11.91

3.4

3.9

—

Psoriatic arthropathies

344

2.38

11.88

2.2

4.0

—

Oesophageal varices

167

3.06

11.82

5.9

4.5

—

Spirochaetal infections, other/unspecified

346

2.37

11.76

4.8

4.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

4.58

11.75

3.2

4.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

232

1288

1.65

11.74

2.8

3.3

—

Fracture of rib(s), sternum and thoracic spine

246

1522

1.63

11.74

3.7

3.9

—

Acute pancreatitis (for exclusion)

161

887

1.83

11.73

4.3

3.9

—

Pruritus

441

2.20

11.71

3.6

3.7

—

Amputation of foot

103

3.69

11.70

3.5

4.9

—

Focal epilepsy, strict definition

158

866

1.84

11.69

3.3

4.2

—

Conduction disorders

236

1150

1.65

11.63

3.7

—

Use of pramipexole

177

1008

1.77

11.55

3.3

4.1

—

Abscess of lung

4.66

11.52

3.7

3.8

—

Juvenile rheumatoid arthirtis

5.11

11.51

3.0

5.5

—

Primary biliary cholangitis (PBC)

4.92

11.49

3.0

2.9

—

Other CVD

175

995

1.77

11.48

3.7

4.0

—

Insulin, fast-acting or short human

279

1787

1.57

11.48

3.4

3.9

—

Alcoholic liver disease

394

2.26

11.46

2.5

4.3

—

Excessive, frequent and irregular menstruation

235

749

1.68

11.45

3.4

3.0

—

Endocarditis

139

3.23

11.42

2.8

4.2

—

Cystic kidney disease, including avohilmo

129

3.33

11.42

4.5

—

Other gastritis (incl. Duodenitis)

173

982

1.77

11.41

3.1

3.7

—

Nonsuppurative otitis media, including avohilmo

205

1049

1.70

11.35

4.3

3.5

—

Allergic urticaria

285

2.48

11.29

5.6

4.0

—

Iridocyclitis

169

956

1.78

11.28

3.5

4.0

—

Molar incisor enamel hypoplasia

163

2.99

11.28

5.6

3.5

—

ILD-related respiratory insufficiency

156

3.09

11.27

7.1

4.8

—

Open wound of head

422

2769

1.44

11.26

3.5

3.8

—

Disorders of skin appendages

338

2255

1.50

11.23

4.0

3.5

—

Colectomy operation

144

778

1.87

11.21

3.0

4.4

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

141

3.17

11.13

2.7

2.6

—

Acidosis

3.86

11.11

2.0

5.8

—

Autoimmune hepatitis, wide definition

126

3.30

11.11

3.0

4.6

—

Osteonecrosis due to drugs

4.53

11.10

4.7

3.7

—

Focal epilepsy

166

939

1.78

11.08

3.4

4.2

—

Other disorders of adrenal gland

168

2.97

11.07

3.5

4.0

—

Pain associated with micturition

100

478

2.11

11.06

3.1

4.2

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

11.22

10.96

9.8

4.2

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

284

2.47

10.92

2.2

4.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

148

3.08

10.91

2.4

2.8

—

Malignant melanoma of skin

345

2.31

10.90

4.5

2.6

—

Osteonecrosis

243

2.59

10.87

5.8

4.3

—

Cholecystitis

119

610

1.97

10.86

3.6

4.1

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.91

10.83

7.5

3.4

—

Acute and subacute iridocyclitis

141

768

1.85

10.70

3.6

4.0

—

Other symptoms and signs involving the circulatory and respiratory systems

257

2.52

10.66

4.3

3.5

—

Peripheral arterial reconstruction

149

827

1.82

10.66

3.0

4.2

—

Thyroiditis, ILD-related definition

362

2.26

10.60

2.9

4.0

—

Glomerulonephritis

388

2.22

10.60

4.2

4.4

—

Other/unspecified dorsalgia

264

1681

1.56

10.58

3.0

3.7

—

Mental and behavioural disorders due to opioids

3.68

10.54

2.4

3.1

—

Use of interferon beta-1a

4.89

10.53

3.3

3.6

—

Malignant neoplasm of oral cavity

4.03

10.51

4.4

2.8

—

Hypertensive heart and/or renal disease

218

972

1.65

10.49

3.3

4.0

—

Other disorders of veins

283

1827

1.53

10.49

3.4

3.5

—

Assault by bodily force

218

2.64

10.47

2.4

3.9

—

Postmenopausal osteoporosis with pathological fracture

243

2.55

10.36

2.8

3.8

—

Hepatomegaly and splenomegaly, not elsewhere classified

7.83

10.34

5.4

4.0

—

Hypotension

153

864

1.78

10.34

3.9

4.1

—

Other arthrosis

353

1610

1.47

10.30

3.0

3.8

—

Fissure and fistula of anal and rectal regions

170

990

1.73

10.29

4.6

3.8

—

Deforming dorsopathies

209

1286

1.63

10.25

3.3

3.8

—

Selective serotonin reuptake inhibitors

681

2674

1.33

10.25

3.1

3.8

—

Familial hypercholesterolemia, with ischemic heart disease

454

2.10

10.19

2.9

4.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

357

2379

1.45

10.19

3.6

—

Abscess of anal and rectal regions

275

2.42

10.16

2.5

4.1

—

Lung diseases due to external agents

124

660

1.90

10.16

4.1

4.2

—

Anterior Iridocyclitis

148

832

1.79

10.15

3.6

4.0

—

Sequelae with surgical and medical care as external cause

161

928

1.75

10.14

4.2

4.1

—

Brain meningioma, including Hilmo

118

3.26

10.14

3.3

3.2

—

Allergic asthma (mode), excluding more controls

105

514

2.00

10.13

2.5

2.7

—

Hypocalcemia

3.61

10.12

2.7

4.5

—

Other disorders of optic [2nd] nerve and visual pathways

240

2.53

10.11

4.6

4.5

—

Other specified/unspecified necrotizing vasculopathies

4.95

10.10

3.4

4.0

—

Diseases of tongue

188

2.74

10.08

4.2

3.9

—

Assault

396

2.16

10.06

2.6

3.9

—

Open wound of forearm

377

2.20

10.06

4.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

221

1389

1.60

9.97

2.4

4.0

—

Glucagon-like peptide-1 (GLP-1) analogues

221

1389

1.60

9.97

2.4

4.0

—

Hypoparathyroidism

125

3.18

9.93

3.6

3.8

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

115

3.29

9.92

9.7

3.9

—

Depression or dysthymia

461

1802

1.40

9.88

3.2

4.0

—

Haemorrhage, not elsewhere classified

141

3.03

9.88

4.4

3.5

—

Hypoplasia of dental enamel , including avohilmo

156

2.89

9.84

5.9

3.5

—

Perforation of tympanic membrane

376

2.18

9.72

4.4

3.9

—

Extreme obesity with alveolar hypoventilation

143

2.99

9.65

2.1

4.7

—

Viral and other specified intestinal infections, including avohilmo

175

1005

1.68

9.64

3.6

—

Herpesviral [herpes simplex] infections

437

2.08

9.61

4.5

4.0

—

Obsessive-compulsive disorder

176

2.75

9.59

3.5

3.6

—

Abnormal findings on diagnostic imaging of other body structures

104

534

1.96

9.51

4.3

3.8

—

Diaphragmatic hernia

277

1853

1.50

9.46

4.3

3.7

—

Other and unspecified tonsillitis

180

899

1.67

9.44

2.8

3.1

—

Allergic asthma (mode)

105

528

1.95

9.42

2.5

2.7

—

Folate deficiency anaemia

5.08

9.41

5.1

4.3

—

Otitis media, unspecified

385

2.10

9.41

4.1

3.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

8.95

9.37

4.6

3.5

—

Hyperlipidaemia, other/unspecified

301

1841

1.48

9.30

3.5

3.8

—

Dermatophytosis

112

595

1.90

9.28

4.8

4.0

—

Ankylosing spondylitis, strict definition

125

3.08

9.26

2.7

3.8

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

8.07

9.26

3.4

3.6

—

Sacroiliitis, not elsewhere classified

125

3.08

9.25

2.1

3.5

—

Stroke, excluding SAH

457

2407

1.37

9.22

3.7

3.8

—

Chronic tubulo-interstitial nephritis

110

3.23

9.20

4.5

4.1

—

Malignant neoplasm of bone and articular cartilage

8.64

9.18

2.8

3.9

—

Other diseases of intestine

120

655

1.85

9.13

3.2

4.1

—

Viral warts

353

2.17

9.13

3.5

4.2

—

Dyshidrosis [pompholyx]

4.88

9.11

4.3

4.8

—

Abnormal weight loss

413

2.08

9.11

3.0

4.1

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

4.66

9.10

2.2

3.4

—

Colon adenocarcinoma

367

2.14

9.05

2.9

2.6

—

Mixed connective tissue disease

4.18

9.04

2.4

4.4

—

Injuries to the hip and thigh

368

2343

1.41

9.04

3.6

3.7

—

Diseases of inner ear

390

2682

1.40

9.00

3.7

—

Alcohol use disorder, Swedish definition

382

2484

1.40

9.00

2.5

3.9

—

Hyperplasia of prostate

267

989

1.53

8.99

4.5

4.0

—

Viral and other specified intestinal infections

136

755

1.77

8.97

3.8

3.6

—

Hidradenitis suppurativa

107

3.22

8.93

2.3

3.5

—

Chronic pancreatitis

499

1.96

8.86

2.1

4.1

—

Primary gonarthrosis, bilateral

390

2348

1.40

8.84

3.2

3.9

—

Pneumothorax

275

2.32

8.82

3.6

—

Schizophrenia or delusion, excluding more controls

185

1134

1.62

8.82

3.1

3.9

—

Brain meningioma

113

3.13

8.80

3.4

3.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

237

1560

1.53

8.78

4.2

3.6

—

Unspecified acute lower respiratory infection

113

613

1.86

8.78

5.3

4.1

—

Microscopic polyangiitis

8.82

8.77

2.9

3.7

—

Vertigo of central origin

3.96

8.77

7.5

4.5

—

Psychiatric diseases

667

2573

1.30

8.76

3.7

3.8

—

Abnormal findings on examination of blood, without diagnosis

360

2319

1.41

8.76

4.4

3.8

—

Diabetic nephropathy, excluding more controls

122

548

1.83

8.71

3.5

3.3

—

Gingival hyperplasia

169

2.72

8.69

3.8

4.7

—

Diseases of pulp and periapical tissues, including avohilmo

717

2889

1.29

8.67

3.5

3.6

—

Visual disturbances

346

2459

1.41

8.63

4.0

3.5

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

4.85

8.63

5.3

3.4

—

Other noninflammatory disorders of vagina

265

2.32

8.63

2.4

3.3

—

Colonic or urogenital fistula

188

1180

1.60

8.61

4.5

3.9

—

Generalized anxiety disorder

503

1.94

8.60

2.7

3.4

—

Ulcerative proctitis

181

2.62

8.60

4.7

4.0

—

Other disorders of nervous system

260

2.34

8.56

5.1

4.3

—

Disorders of vestibular function (Vertigo)

337

2326

1.42

8.51

3.7

—

Recurrent or chronic depression

240

1093

1.53

8.49

2.5

3.9

—

Phobic anxiety disorders

376

2.08

8.46

2.8

3.6

—

Disorders of continuity of bone

351

2.13

8.46

4.5

4.1

—

Benign neoplasm: Colon, unspecified

200

1280

1.57

8.46

3.9

—

Soft tissue disorders related to use, overuse and pressure

190

1201

1.59

8.45

3.7

3.8

—

Hernia of abdominal wall

324

2287

1.42

8.42

3.5

3.8

—

Optic neuritis

127

2.95

8.41

3.9

3.5

—

Amyloidosis

3.38

8.40

3.0

4.7

—

Ulcerative rectosigmoiditis

256

2.33

8.38

4.3

4.5

—

Pneumonitis due to solids and liquids

366

2.10

8.37

2.6

4.5

—

Psoriatic arthropathies, ICD10

386

2.07

8.36

2.2

4.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

6.80

8.32

5.9

3.5

—

Malignant neoplasm of stomach, including Hilmo

167

2.66

8.29

2.6

2.5

—

Other noninfective disorders of lymphatic vessels and lymph nodes

118

3.01

8.22

2.1

3.7

—

Abnormal findings on diagnostic imaging of central nervous system

168

2.65

8.21

4.3

4.1

—

Other diseases of pancreas

316

2.17

8.21

3.6

3.8

—

Abnormality of white blood cells, not elsewhere classified

4.95

8.21

10.2

3.3

—

Other shoulder lesions

316

2.17

8.20

3.1

4.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

124

586

1.78

8.18

3.1

3.0

—

Atypical mycobacterium lung infection

4.89

8.18

7.9

3.9

—

Sequelae of other external causes

204

2.48

8.15

3.9

4.2

—

Other and unspecified follicular disorders

146

2.78

8.15

6.4

4.2

—

Other psoriatic arthropathies

370

2.07

8.14

2.2

4.0

—

Panhypopituitarism

3.85

8.13

3.1

4.3

—

Bronchitis, not specified as acute or chronic

298

2.20

8.11

4.5

4.6

—

Malignant neoplasm of oral cavity, including Hilmo

103

3.14

8.11

4.5

2.6

—

Malignant neoplasm, without specification of site

3.42

8.10

5.3

3.0

—

Ovarian dysfunction

169

2.62

8.10

2.7

3.1

—

Hypertensive Heart Disease

191

918

1.59

8.08

3.1

4.0

—

Personality disorders, excluding more controls

136

797

1.71

8.08

2.7

3.7

—

Open wound of lower leg

112

623

1.81

8.07

3.2

4.2

—

Other neurological diseases

518

3060

1.32

8.00

3.6

3.7

—

Hypersplenism

10.20

7.97

7.1

3.4

—

Other and unspecified acquired haemolytic anaemias

4.81

7.96

8.3

3.9

—

Ventral hernia

182

1158

1.58

7.92

3.4

3.8

—

Car occupant injured in other and unspecified transport accidents

121

693

1.76

7.90

3.7

—

100

3.17

7.89

4.4

5.0

—

Malignant neoplasm of breast, HER-negative

103

539

1.84

7.87

3.1

2.4

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

9.71

7.85

2.1

3.8

—

In situ neoplasms

288

2018

1.43

7.84

5.2

3.5

—

Fracture of foot, except ankle

165

1028

1.61

7.84

3.1

3.8

—

Carrier of infectious disease

3.36

7.84

4.1

—

Chondropathies

102

557

1.84

7.82

3.2

4.1

—

Idiopathic gout

425

1.97

7.76

4.4

4.6

—

Other abnormalities of plasma proteins

3.97

7.76

4.0

3.6

—

Otitis externa, unspecified

412

1.98

7.70

3.2

4.2

—

412

2663

1.35

7.70

2.5

3.9

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

124

624

1.74

7.70

2.6

3.2

—

Panic disorder

426

1.96

7.67

2.6

3.7

—

Malignant neoplasm of stomach

145

2.72

7.67

2.5

—

Congenital malformations of the urinary system

235

2.33

7.67

4.3

4.9

—

Stroke, including SAH

464

2510

1.33

7.67

3.7

3.8

—

Monocytic leukaemia

8.56

7.67

19.1

5.0

—

Operations 2 for CAVS

238

1555

1.48

7.64

4.2

3.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

238

1555

1.48

7.64

4.2

3.8

—

Other embolism and thrombosis

505

1.88

7.61

4.4

3.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

117

651

1.75

7.57

3.9

4.2

—

Amputation of thigh

124

2.87

7.57

3.5

4.9

—

Calcific aortic valvular stenosis, operated

238

1559

1.48

7.55

4.2

3.8

—

Calcific aortic valvular stenosis

238

1559

1.48

7.55

4.2

3.8

—

Neuralgia and neuritis, unspecified

164

2.59

7.52

3.8

4.1

—

Allergic bronchopulmonary aspergillosis (ABPA)

14.31

7.52

10.3

7.1

—

Myocardial infarction, without ST-elevation

311

2004

1.41

7.52

3.4

4.0

—

Calcific aortic valvular stenosis, including rheumatic fever

238

1559

1.47

7.50

4.2

3.8

—

Herpesviral [herpes simplex] infections, including avohilmo

156

970

1.62

7.49

3.8

3.6

—

UC patients in KELA-register (code 208), prior to 1994

159

2.62

7.47

3.9

4.1

—

Biological medicines for asthma

3.60

7.46

1.6

3.9

—

Other renal tubulo-interstitial diseases

3.59

7.45

3.5

4.4

—

Malignant neoplasm of breast, ER-negative, including Hilmo

108

568

1.79

7.45

3.1

2.4

—

Hepatocellular carcinoma, including Hilmo

3.58

7.44

2.4

2.8

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

106

595

1.79

7.44

2.5

3.3

—

Spinal instabilities

3.31

7.41

3.0

3.9

—

Polycystic kidney disease

3.09

7.36

3.5

3.9

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

231

1551

1.47

7.35

3.0

3.5

—

Other specific arthropathies, wide

3.66

7.34

2.7

4.3

—

Disorders of muscles

365

2.01

7.31

4.4

4.2

—

Reactive arthropathies

285

2.16

7.31

4.0

4.2

—

Sequelae of injuries, of poisoning and of other consequences of external causes

155

969

1.61

7.30

3.9

4.0

—

Chronic sinusitis

265

1853

1.43

7.27

4.0

3.5

—

Occupational exposure to risk-factors

127

2.80

7.26

6.8

5.3

—

Other viral hepatitis, including avohilmo

185

2.45

7.25

2.6

3.8

—

Bronchiectasis

326

2.08

7.25

3.5

4.7

—

Other diseases of stomach and duodenum

229

2.29

7.20

3.6

—

Tobacco use

192

2.42

7.19

3.3

4.3

—

Hallux valgus (acquired)

204

963

1.52

7.17

3.8

3.7

—

Amyloidosis, other/unspecified

3.33

7.17

2.5

5.0

—

Diseases of male genital organs

346

1257

1.39

7.15

4.2

4.0

—

Clear cell adenocarcinoma of kidney

117

2.85

7.12

4.0

2.4

—

Malignant neoplasm of other and unspecified parts of biliary tract

6.15

7.12

2.3

3.0

—

Emotionally unstable personality disorder

362

2.00

7.10

2.4

3.4

—

Transport accidents

280

1648

1.42

7.08

3.2

3.7

—

Postzoster neuralgia

3.70

7.08

4.0

4.8

—

Encephalitis

107

2.95

7.04

3.6

3.8

—

Allergic purpura

3.13

7.04

3.7

3.5

—

Atopic dermatitis, strict definition with reimbursement

172

1068

1.55

6.98

3.1

3.3

—

Corns and callosities

245

2.23

6.98

3.2

4.2

—

Malignant neoplasm of pancreas, including Hilmo

232

2.26

6.98

2.3

2.9

—

Dermatopolymyositis (FG)

4.06

6.94

4.5

4.9

—

Listeriosis

9.90

6.91

16.9

2.9

—

Listeriosis, including avohilmo

9.88

6.90

16.9

2.9

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

11.57

6.90

12.4

4.4

—

Crystal arthropathies, rheuma endpoint

3.25

6.90

4.7

4.6

—

Explicit fungal Sepsis

6.41

6.89

2.5

4.7

—

Explicit fungal Sepsis, including avohilmo

6.41

6.89

2.5

4.7

—

Other encephalitis

103

2.97

6.89

3.6

3.9

—

Hypertensive Renal Disease

148

2.60

6.89

3.9

3.5

—

Small fibre neuropathy

114

2.86

6.88

6.2

4.7

—

Pyothorax

178

2.45

6.87

3.7

4.6

—

Ulcerative ileocolitis

114

2.84

6.86

3.3

3.9

—

Myocarditis

120

2.77

6.80

4.2

3.8

—

389

2615

1.33

6.76

2.5

3.9

—

Other sleep disorders

404

1.92

6.74

3.2

4.5

—

All dysplastic lesions of the vagina

3.43

6.72

2.5

3.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

121

706

1.67

6.69

3.9

4.1

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

10.88

6.69

8.6

5.9

—

Palindromic rheumatism

5.66

6.69

2.3

5.5

—

Congenital malformations, deformations and chromosomal abnormalities

354

2500

1.34

6.65

3.5

—

Subjective visual disturbances

172

1127

1.53

6.65

3.5

3.8

—

Other crystal arthropathies

3.17

6.64

4.7

3.6

—

Primary hyperparathyroidism

464

1.85

6.61

3.1

4.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

3.21

6.59

2.7

3.1

—

Pediculosis, acariasis and other infestations

213

2.28

6.56

4.0

4.4

—

315

2078

1.37

6.55

5.3

3.7

—

Chronic iridocyclitis

176

2.42

6.54

3.5

4.1

—

Other and unspecified psoriasis

252

2.16

6.54

3.6

4.3

—

Pollen allergy

118

699

1.67

6.54

3.0

3.5

—

Other viral hepatitis

176

2.41

6.53

2.7

3.9

—

Brain glioblastoma

6.30

6.51

3.3

4.7

—

Chorioretinal inflammation

101

2.92

6.50

3.5

4.1

—

Elevated blood glucose level

340

1.99

6.50

4.5

3.9

—

Ischaemic Stroke, excluding all haemorrhages

415

2327

1.32

6.49

3.6

3.8

—

Striking against or struck by other objects

217

1497

1.45

6.46

3.5

3.8

—

Cerebral palsy and other paralytic syndromes

446

1.85

6.46

3.6

4.0

—

Thrombotic microangiopathy

8.53

6.42

6.2

3.8

—

Congenital malformations of the urinary system, including avohilmo

261

2.13

6.40

4.3

4.7

—

Malignant neoplasm of bone and articular cartilage of limbs

11.68

6.40

2.4

2.8

—

Scabies, including avohilmo

527

1.77

6.39

3.1

3.8

—

Tubulo-interstitial nephritis, not specified as acute or chronic

222

2.23

6.38

2.7

4.1

—

Erythema nodosum

3.07

6.37

2.2

3.3

—

Brain glioblastoma and astrocytoma

5.25

6.35

3.3

3.9

—

Primary ovarian failure

5.24

6.35

2.3

3.7

—

240

1452

1.43

6.34

3.7

3.9

—

Severe visual impairment, binocular

7.42

6.33

4.1

5.4

—

Non-small cell lung cancer, squamous, helper endpoint

204

2.28

6.32

2.5

4.5

—

Inflammatory disease of cervix uteri

179

2.37

6.31

3.0

3.7

—

Anomalies of dental arch relationship, including avohilmo

125

694

1.64

6.31

4.0

3.6

—

Enteropathic arthropathies

3.39

6.30

2.3

4.5

—

Meningitis

167

2.42

6.29

3.8

4.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

121

2.67

6.29

4.5

3.5

—

Personal history of malignant neoplasm

283

2.07

6.27

5.2

3.2

—

Mental and behavioural disorders due to sedatives or hypnotics

211

2.25

6.26

1.8

3.8

—

Malignant neoplasm of pancreas

192

2.31

6.26

2.3

2.7

—

Use of disulfiram, acamprosate or naltrexone

270

2.09

6.25

2.9

4.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

6.52

6.25

3.1

3.4

—

Dermatopolymyositis

3.75

6.24

4.5

5.1

—

Complications following infusion, transfusion and therapeutic injection

3.74

6.24

2.4

5.1

—

Olecranon bursitis

231

2.19

6.23

3.4

4.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

293

2128

1.37

6.23

2.6

3.9

—

Pustular psoriasis

156

2.47

6.21

2.5

3.7

—

Speech disturbances, not elsewhere classified

388

1.90

6.20

3.0

3.9

—

Other/unspecified synovitis and tenosynovitis

409

1.87

6.20

4.7

4.1

—

Faecal incontinence

367

1.92

6.19

4.1

4.0

—

Schizophrenia or delusion

185

1251

1.48

6.18

3.1

3.7

—

Meniscus derangement

335

1650

1.35

6.18

3.7

3.8

—

Schizophrenia, schizotypal and delusional disorders

186

1260

1.48

6.16

3.1

3.7

—

Haemophagocytic lymphohistiocytosis

17.79

6.16

8.0

4.3

—

Other specified disorders of kidney and ureter

110

2.77

6.14

5.3

4.6

—

Nonalcoholic fatty liver disease

354

1.93

6.14

2.3

4.1

—

Other and unspecified injuries of ankle and foot

139

2.55

6.12

3.3

4.1

—

Alcohol use disorder, ICD-based

269

1951

1.38

6.12

2.7

4.0

—

Postprocedural disorders of digestive system, not elsewhere classified

122

2.66

6.08

3.6

4.2

—

Benign neoplasm: Sigmoid colon

141

904

1.57

6.07

3.6

4.1

—

Scoliosis

321

1.98

6.06

2.4

4.2

—

Benign neoplasm: Transverse colon

478

1.79

6.05

2.8

4.3

—

Acute lymphadenitis

183

2.32

6.02

7.4

4.3

—

Infarction of spleen

6.08

5.94

9.6

3.7

—

Reactive arthropathies, FINNGEN

216

2.19

5.94

3.1

4.4

—

Inflammatory diseases of prostate (prostatitis)

540

1.73

5.92

2.9

4.0

—

Malignant neoplasm of corpus uteri, including Hilmo

236

2.13

5.91

2.3

2.6

—

Malignant neoplasm of adrenal gland, including Hilmo

8.30

5.90

4.0

3.7

—

Malignant neoplasm of oesophagus

3.56

5.90

1.8

3.6

—

Acute laryngitis and tracheitis

353

1.91

5.89

4.2

3.1

—

Pediculosis, acariasis and other infestations, including avohilmo

108

654

1.66

5.87

3.2

3.7

—

Duodenal ulcer

475

1.78

5.87

2.9

4.0

—

Malignant neoplasm of corpus uteri

211

2.20

5.84

2.4

2.5

—

Paraplegia, diplegia of upper limbs

3.06

5.84

4.4

4.0

—

Spondylolisthesis/Spondylolysis

127

803

1.59

5.82

3.4

4.1

—

Syphilis

2.91

5.81

2.0

3.8

—

Syphilis, including avohilmo

2.91

5.81

2.0

3.8

—

Right bundle-branch block

149

2.45

5.81

3.9

4.0

—

Disorders of oesophagus in diseases classified elsewhere

3.13

5.80

4.3

3.9

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.83

5.78

4.9

2.8

—

Portal vein thrombosis

3.31

5.77

6.5

4.6

—

Disorders of puberty, all

3.52

5.76

4.0

6.0

—

Hepatocellular carcinoma

3.51

5.75

2.5

3.1

—

Other diseases of oesophagus

384

1.86

5.74

3.4

3.9

—

Diabetic neuropathy

513

1.74

5.74

3.8

3.6

—

Diseases of salivary glands

210

1478

1.43

5.73

3.2

3.7

—

Oesophageal obstruction

138

2.50

5.72

2.5

3.9

—

Fracture of femur

201

1262

1.44

5.72

3.6

3.9

—

Diabetic nephropathy

122

758

1.60

5.71

3.5

3.6

—

Benign neoplasm of other and unspecified endocrine glands

531

1.72

5.71

4.7

4.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

386

2715

1.30

5.68

3.6

3.5

—

Lupus nephritis

13.58

5.66

3.9

6.3

—

Skin changes due to chronic exposure to nonionizing radiation

296

1996

1.35

5.65

5.5

3.7

—

Viral hepatitis, including avohilmo

234

2.11

5.64

2.6

3.9

—

Vasomotor and allergic rhinitis

217

1504

1.41

5.64

3.3

3.5

—

Asthma and opportunity respiratory infection

189

2.25

5.63

4.7

4.9

—

Lichen simplex chronicus and prurigo

235

2.10

5.59

3.3

3.9

—

Alzheimer disease

128

1409

0.65

5.59

4.7

3.8

—

Tuberculosis, IBD comorbidity

262

2.04

5.58

4.4

4.1

—

Care involving use of rehabilitation procedures

199

2524

0.71

5.56

3.8

3.6

—

Malignant neoplasm of rectum

276

2.00

5.54

3.1

2.8

—

Specific personality disorders

125

798

1.57

5.51

2.7

3.5

—

Unspecified misadventure during surgical and medical care

224

2.12

5.47

2.5

4.2

—

Other sexually transmitted chlamydial diseases

147

2.40

5.46

3.1

2.9

—

Other mycoses, not elsewhere classified/unspecified

8.39

5.45

6.3

2.7

—

Erosion of teeth , including avohilmo

155

1040

1.50

5.44

2.9

3.6

—

Malignant neoplasm of heart, mediastinum and pleura

5.29

5.43

5.0

3.9

—

Mental and behavioural disorders due to alcohol

328

2380

1.32

5.40

2.6

3.9

—

Visual field defects

335

1.90

5.40

3.9

4.0

—

Other or unspecified common variable immunodeficiency

9.77

5.39

5.3

4.7

—

Crowding of teeth, including avohilmo

298

1.87

5.38

4.1

3.1

—

Allergic contact dermatitis

473

1.74

5.38

2.7

3.7

—

Systemic disorders of connective tissue in diseases classified elsewhere

9.66

5.38

5.5

3.5

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

9.63

5.37

3.5

3.2

—

Viral infections of the central nervous system

239

2.07

5.36

4.8

3.9

—

Degeneration of macula and posterior pole

358

2125

1.30

5.36

3.8

—

Discitis, unspecified

3.24

5.35

2.5

3.8

—

170

1089

1.46

5.30

3.7

4.0

—

Intestinal malabsorption

162

2.31

5.29

2.9

3.9

—

Other bursopathies

528

1.70

5.29

2.8

4.1

—

Other forms of systemic lupus erythematosus

5.58

5.29

2.7

4.5

—

Hyperkinetic disorders, excluding more controls

300

1.90

5.28

2.5

3.1

—

Idiopathic pulmonary fibrosis

374

1.84

5.27

4.6

4.4

—

Personal history of other diseases and conditions

350

1.86

5.27

3.5

2.9

—

Systemic sclerosis (FG)

3.09

5.24

3.3

4.3

—

Other benign neoplasms of skin

249

1834

1.36

5.23

3.9

3.7

—

Ménière disease

382

1.82

5.22

4.1

4.3

—

Heartburn

411

1.79

5.22

3.2

4.4

—

Malignant neoplasm of endocrine gland, including Hilmo

195

2.17

5.21

6.0

2.7

—

Endometriosis

176

699

1.47

5.19

2.9

3.0

—

Allergic rhinitis

176

1207

1.44

5.19

2.9

3.6

—

Somatoform disorder

577

1.65

5.17

3.5

4.1

—

Other and unspecified nonorganic psychotic disorders

102

631

1.62

5.16

3.5

—

Scabies

164

2.28

5.15

3.8

4.1

—

Pulmonary eosinophilia, not elsewhere classified

3.85

5.13

6.3

4.1

—

Other noninflammatory disorders of uterus, except cervix

128

550

1.56

5.12

3.8

3.2

—

LSIL lesion of the vagina

3.82

5.12

2.9

3.4

—

Degenerative diseases of the nervous system

149

1570

0.68

5.11

4.4

3.7

—

Orchitis and epididymitis

370

1.82

5.11

3.9

—

Actinic keratosis

285

1952

1.33

5.11

5.6

3.7

—

Erythema multiforme

2.89

5.11

3.4

4.1

—

Tongue abnormality

237

2.05

5.11

4.3

—

Other disorders of bladder

511

1.69

5.10

4.1

4.2

—

Leiomyosarcoma

8.60

5.10

1.9

3.7

—

Intracranial and intraspinal abscess and granuloma

3.65

5.09

5.9

3.4

—

Thyroiditis, unspecified

4.54

5.08

2.2

3.7

—

Post-traumatic stress disorder

217

2.08

5.08

3.0

3.1

—

Benign neoplasm: Caecum

482

1.71

5.07

4.0

—

Malignant neoplasm of rectum, including Hilmo

328

1.87

5.06

3.1

2.7

—

Malignant neoplasm of tongue, including Hilmo

3.60

5.06

4.3

3.4

—

Disorders of puberty

3.47

5.06

2.6

5.5

—

Diabetic retinopathy, excluding more controls

176

676

1.46

5.05

3.8

3.2

—

Autoimmune hyperthyroidism

153

2.30

5.03

3.0

3.7

—

Other infective otitis externa

212

2.09

5.00

3.5

3.6

—

Neuromuscular dysfunction of bladder

344

1.84

5.00

3.0

4.1

—

Disorders of adult personality and behaviour

149

1011

1.48

4.99

2.6

3.6

—

Alzheimer’s disease, strict definition

1193

0.62

4.98

4.0

3.7

—

Nail disorders

309

1.89

4.97

4.2

4.3

—

Myositis

2.77

4.96

5.5

4.9

—

Viral hepatitis

226

2.05

4.96

2.6

3.9

—

Other chondrocalcinosis

3.30

4.94

4.2

4.1

—

Artificial joint re-operation

289

1.92

4.93

2.7

4.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

3.15

4.92

2.2

2.8

—

Viral infections of the central nervous system, including avohilmo

261

1.97

4.92

4.6

3.8

—

Follow-up examination after treatment for malignant neoplasms

310

1.88

4.92

3.1

3.3

—

Certolizumab pegol

3.53

4.91

3.3

3.2

—

Separation of retinal layers (serosa)

155

2.28

4.90

4.3

4.5

—

Hydrocele

479

1.70

4.90

4.8

4.1

—

Monoarthritis, not elsewhere classified

130

2.41

4.90

4.4

4.0

—

Myocardial infarction

353

1916

1.29

4.88

3.3

3.8

—

Left bundle-branch block

297

1.90

4.87

4.4

4.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

125

823

1.53

4.86

3.4

4.0

—

Nonischemic cardiomyopathy

443

1.73

4.84

5.7

4.2

—

Malignant neoplasm of adrenal gland

9.42

4.84

4.7

4.4

—

Other and unspecified mood [affective] disorders

195

2.12

4.82

2.2

3.8

—

Chronic rhinitis, nasopharyngitis and pharyngitis

195

1400

1.40

4.82

3.3

3.6

—

Chronic hepatitis, not elsewhere classified

119

2.47

4.81

2.7

3.8

—

Schizophrenia

550

1.64

4.81

2.7

3.8

—

KRA_PSY_EATING, excluding more controls

193

2.11

4.81

3.3

3.0

—

Keratitis

222

1629

1.37

4.81

3.8

—

Polyarteritis nodosa

5.94

4.81

5.8

3.2

—

Benign neoplasm of meninges

422

1.74

4.81

4.4

4.0

—

Leiomyosarcoma, including Hilmo

6.64

4.81

1.8

3.2

—

Gout due to impairment of renal function

3.50

4.79

3.9

3.8

—

Malignant neoplasm of oesophagus, including Hilmo

2.77

4.79

1.7

3.0

—

Late syphilis

3.35

4.79

2.2

3.4

—

Disorder of lipoprotein metabolism, unspecified

590

1.62

4.78

3.1

4.3

—

Fracture of skull and facial bones

136

915

1.49

4.78

3.2

4.2

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

3.20

4.78

1.8

1.9

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

285

1.91

4.76

3.1

2.8

—

Malignant neoplasm of tongue

4.48

4.76

4.4

3.0

—

Isolated proteinuria

2.64

4.75

3.1

3.8

—

Bell's palsy

431

1.73

4.75

4.5

4.2

—

Other obstructive and reflux uropathy

132

2.37

4.75

5.4

5.0

—

Paralytic strabismus

279

1.92

4.73

4.0

4.2

—

Tonsillectomy and adenotomy

293

1551

1.32

4.72

3.1

3.5

—

Chronic myeloid leukaemia

7.48

4.72

4.9

4.4

—

Malignant neoplasm of nasal cavity and sinuses

7.38

4.69

8.1

4.7

—

Sudden idiopathic hearing loss

403

1.75

4.69

4.4

4.3

—

Alzheimer’s disease (Late onset)

1127

0.62

4.69

4.4

3.7

—

Malignant neoplasm of endocrine gland

171

2.18

4.68

6.0

2.6

—

Status post-ami

209

1151

1.38

4.68

3.7

3.8

—

Open wound of ankle and foot

381

1.77

4.68

4.2

4.4

—

Intracranial injury

389

2879

1.26

4.68

3.4

3.7

—

ILD and respiratory illness in diseases classified elsewhere

6.40

4.67

4.2

3.4

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

273

1.92

4.67

2.9

2.7

—

Open wound of wrist and hand

283

2088

1.31

4.66

3.7

—

Golimumab

2.66

4.66

2.3

3.6

—

Obesity, other/unspecified

188

1351

1.40

4.64

2.3

3.8

—

Single spontaneous delivery

125

986

0.67

4.64

3.8

3.3

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.59

4.63

7.2

3.7

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

3.37

4.62

5.8

3.3

—

Gonarthrosis, primary, with knee surgery

401

2486

1.26

4.61

3.4

3.9

—

Amputation of ankle bones

2.72

4.61

2.6

4.1

—

Other noninflammatory disorders of cervix uteri

179

2.14

4.61

2.9

3.4

—

Diabetic retinopathy

237

1087

1.36

4.60

3.7

3.2

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.64

4.58

4.0

3.7

—

Unspecified nephritic syndrome

2.85

4.58

4.0

3.7

—

Other and unspecified diseases of blood and blood-forming organs

2.59

4.57

6.8

3.7

—

Ovarian cyst

177

711

1.43

4.56

2.7

3.0

—

Late syphilis, including avohilmo

3.11

4.55

2.4

4.1

—

Major coronary heart disease event excluding revascularizations

422

2229

1.25

4.54

3.5

3.8

—

6.99

4.53

4.5

3.9

—

Other extrapyramidal and movement disorders in other diseases

166

1174

1.42

4.52

2.8

4.0

—

Superficial injury of hip and thigh

105

677

1.56

4.52

4.3

—

Campylobacter enteritis

2.68

4.51

3.3

4.3

—

Other/unspecified reactive arthropathies

228

1.99

4.50

3.2

4.1

—

Hypermobility syndrome

123

2.37

4.49

1.6

3.7

—

Other headache syndromes

234

1745

1.34

4.48

3.3

3.6

—

Secondary right heart disease

168

2.17

4.48

6.4

4.5

—

Temporomandibular joint disorders, including avohilmo

243

1770

1.33

4.48

2.9

3.3

—

Disturbances of skin sensation

153

1068

1.44

4.47

3.3

3.4

—

Impetigo

168

2.16

4.47

4.3

4.1

—

Drug-induced adrenocortical insufficiency

2.98

4.47

3.6

4.1

—

Tuberculosis, wide

292

1.86

4.46

4.3

4.2

—

Toxic effects of substances chiefly nonmedicinal as to source

409

1.72

4.46

2.4

4.3

—

Vascular disorders of the intestines

278

1.88

4.45

3.1

4.0

—

Disorders of optic nerve, not elsewhere classified

2.73

4.45

4.3

4.6

—

Delivery

127

987

0.68

4.44

3.8

3.3

—

Unspecified mental disorder

224

1669

1.35

4.42

2.8

3.8

—

Atopic dermatitis

326

2029

1.28

4.41

3.5

3.4

—

Artrosis, including avohilmo

506

2263

1.23

4.38

3.6

3.8

—

Cardiomyopathy (excluding other)

518

1.63

4.38

3.7

4.0

—

Pustulosis palmaris et plantaris

131

2.31

4.37

2.3

4.2

—

Other bacterial agents as the cause of diseases classified to other chapters

3.43

4.37

3.3

3.1

—

Pleural plaque with presence of asbestos

353

1.77

4.36

6.0

4.4

—

Primary adrenocortical insufficiency

4.05

4.34

3.1

3.2

—

Kela-code for severe mental illness

204

1504

1.36

4.34

2.8

3.8

—

Cardiomyopathies, Primary/intrinsic

512

1.63

4.33

3.7

4.0

—

Embedded and impacted teeth

131

721

1.48

4.33

3.5

3.2

—

Osteosarcoma, including Hilmo

12.19

4.32

2.4

3.8

—

Chronic viral hepatitis

138

2.26

4.32

2.6

3.0

—

Malignant neoplasm of tonsil and base of tongue

4.00

4.31

6.1

3.8

—

Malignant neoplasm of cervix uteri

5.57

4.30

1.5

1.8

—

Malignant neoplasm of small intestine, including Hilmo

2.81

4.30

4.9

2.8

—

Hypoplasia of dental enamel, prenatal

4.92

4.29

4.1

4.7

—

Other disorders starting during childhood or adolecense, excluding more controls

150

2.18

4.29

4.2

3.3

—

Alzheimer disease, including avohilmo

163

1572

0.72

4.27

4.5

3.7

—

Systemic sclerosis

2.73

4.27

3.3

3.5

—

Tuberculosis, wide, including avohilmo

297

1.83

4.25

4.3

4.2

—

Hyperfunction of pituitary gland

152

2.19

4.25

6.3

4.0

—

Pilonidal cyst

247

1.91

4.24

3.7

4.1

—

Personal history of medical treatment

3.95

4.23

11.7

4.1

—

Dissociative [conversion] disorders

102

2.47

4.22

2.9

4.0

—

Personality disorders

136

940

1.45

4.22

2.7

3.6

—

Carcinoma in situ of skin of other and unspecified parts of face

409

1.70

4.21

8.6

4.4

—

Ingrowing nail

179

2.08

4.21

4.3

3.9

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

357

1.75

4.19

4.1

—

Varicella [chickenpox]

153

2.18

4.19

6.6

4.7

—

Osteopathy in diseases classified elsewhere

4.49

4.18

4.9

4.0

—

Asthma and allergy, excluding more controls

280

1.84

4.18

3.0

2.8

—

Hypoplasia of dental enamel, prenatal , including avohilmo

3.40

4.16

3.7

5.6

—

Mixed conductive and sensorineural hearing loss

526

1.61

4.14

4.0

4.5

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

181

2.06

4.09

2.0

4.0

—

Social phobias

229

1.93

4.09

2.9

3.7

—

Systemic sclerosis, icd10

2.66

4.08

3.3

3.6

—

Malignant neoplasm of accessory sinuses

10.70

4.08

1.7

5.4

—

Varicella [chickenpox], including avohilmo

195

2.02

4.07

6.7

4.5

—

Aortic valve malfunction, age under 60 years

338

1.76

4.07

3.0

4.4

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.40

4.07

4.9

3.6

—

Other diseases of peritoneum

155

2.15

4.07

3.1

3.9

—

Fibrosis of liver

4.35

4.07

3.6

4.2

—

Anorexia

3.39

4.06

5.1

4.5

—

Complications following abortion and ectopic and molar pregnancy

2.53

4.06

3.3

3.4

—

Necrosis of pulp, including avohilmo

342

2697

1.26

4.04

3.4

3.5

—

Other pulmonary heart/vessel disease

196

2.01

4.04

6.2

4.6

—

Malignant neoplasm of accessory sinuses, including Hilmo

6.71

4.03

1.9

3.8

—

Other disorders of the genitourinary system

530

1.59

4.03

4.1

3.9

—

HSIL lesion of the vagina

3.96

4.02

2.7

3.8

—

Fracture of shoulder and upper arm

238

1816

1.31

4.00

3.3

3.8

—

Other disorders of penis

415

1.67

3.99

3.5

4.2

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

124

2.28

3.98

5.1

4.0

—

Paralytic ileus

137

2.21

3.97

3.5

3.7

—

Amenorrhoea

170

2.07

3.95

2.5

2.9

—

Acne

317

1.76

3.95

3.4

3.1

—

Nephrotic syndrome

131

2.24

3.95

3.4

4.5

—

Pleural plaque

440

1.65

3.94

5.9

3.8

—

Malignant neoplasm of small intestine

3.16

3.94

3.7

3.2

—

Burkitt lymphoma, helper endpoint

14.47

3.94

2.2

5.0

—

Diabetic retinopathy, strict definition

117

706

1.48

3.93

3.6

3.4

—

Acquired absence of organs, not elsewhere classified

3.87

3.92

5.4

4.4

—

Childhood asthma (age<16)

185

1.90

3.89

3.9

2.1

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

3.03

3.88

3.2

3.8

—

Adult respiratory distress syndrome

3.03

3.88

4.7

3.7

—

Progressive systemic sclerosis

6.27

3.87

2.7

3.9

—

Benign neoplasm of mouth and pharynx

435

1.64

3.85

4.2

3.7

—

Vitamin B12 deficiency anaemia

412

1.66

3.85

3.2

4.1

—

Arthropathy in Crohn disease

4.38

3.85

2.1

2.5

—

Malignant neoplasm of eye and adnexa

6.14

3.84

2.6

3.8

—

Fibrosarcoma, including Hilmo

6.14

3.84

1.8

4.1

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.80

3.84

6.9

4.2

—

Other disorders of glucose regulation and pancreatic internal secretion

337

1.73

3.83

3.4

4.3

—

Bacterial meningitis

120

2.28

3.82

3.7

4.0

—

Restless leg syndrome

585

1.55

3.81

3.3

3.9

—

Actinomycosis

9.11

3.81

5.7

1.9

—

Use of glatiramer acetate

3.74

3.81

2.3

2.9

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

4.00

3.81

2.9

2.7

—

Actinomycosis, including avohilmo

9.06

3.81

5.7

1.9

—

Malignant neoplasm of oropharynx, including Hilmo

3.73

3.81

3.8

3.7

—

Other disorders of breast

476

1.60

3.78

3.2

3.7

—

Asthma and allergy

290

1.77

3.76

3.0

2.7

—

Alcohol dependence

161

1173

1.38

3.76

2.7

4.1

—

Other demyelinating diseases of the central nervous system

102

2.37

3.75

3.8

3.6

—

Injury of cranial nerves

5.17

3.73

7.5

3.0

—

Cardiomyopathy

113

774

1.47

3.72

3.6

3.9

—

Alcohol abuse, main dg, excluding more controls

525

1.57

3.72

1.9

4.1

—

Other diseases of spinal cord

109

2.32

3.70

4.9

5.2

—

Fibrosarcoma

6.83

3.70

1.9

4.1

—

Childhood asthma (age<16), excluding more controls

183

1.88

3.69

4.0

2.1

—

Polypectomy (DHB20)

255

0.31

3.68

2.0

4.5

—

Diabetic maculopathy, excluding more controls

402

1.65

3.68

3.1

4.3

—

Bitten or struck by other mammals

402

1.65

3.68

4.8

4.1

—

Common variable immunodeficiency

4.57

3.67

4.9

3.8

—

Other superficial injuries of ankle and foot

4.54

3.66

2.7

3.7

—

Bulimia nervosa (incl. atypical)

2.71

3.66

3.1

3.9

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.39

3.66

4.3

3.8

—

Fall on and from stairs and steps

164

1205

1.37

3.65

3.8

4.0

—

Blindness, monocular

3.81

3.63

4.2

4.7

—

Crossbite

301

1.72

3.61

4.8

3.5

—

Mixed hyperlipidaemia

163

2.05

3.61

4.7

4.5

—

Thyrotoxicosis, other and/or unspecified

115

796

1.45

3.61

3.6

3.8

—

Malignant neoplasm of oropharynx

4.06

3.61

4.1

4.2

—

Drug-induced systemic lupus erythematosus

4.92

3.59

3.7

4.5

—

Use of teriflunomide

4.85

3.57

1.8

4.5

—

Superficial injury of ankle and foot

452

1.60

3.56

5.1

4.0

—

Papilloedema, unspecified

2.53

3.56

4.4

4.3

—

Deviated nasal septum

198

1501

1.32

3.55

4.4

3.6

—

Nosocomial condition (hospital)

5.46

3.54

1.9

4.1

—

Other contact dermatitis

278

1.77

3.54

3.2

3.6

—

Disorders of magnesium metabolism

3.73

3.54

3.4

3.9

—

Carcinoma in situ of skin of scalp and neck

131

2.17

3.54

8.9

4.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

6.35

3.53

3.4

4.5

—

Liposarcoma, including Hilmo

5.40

3.53

2.7

3.9

—

Other keratitis

399

1.64

3.53

4.0

4.3

—

Cushing syndrome

3.69

3.52

4.7

4.1

—

Malignant neoplasm of testis, including Hilmo

3.66

3.51

5.9

3.1

—

Malignant neoplasm of eye and adnexa, including Hilmo

3.93

3.50

3.3

2.9

—

Redundant prepuce, phimosis and paraphimosis

120

829

1.43

3.49

3.0

3.9

—

Right hemicolectomy

251

1.81

3.46

2.7

4.2

—

Other metabolic disorders

503

1.56

3.46

5.5

4.0

—

Disorders of endocrine glands in diseases classified elsewhere

7.68

3.46

4.6

6.1

—

Atypical facial pain

159

2.03

3.45

1.6

3.8

—

Persistent mood disorders

109

754

1.45

3.45

4.1

3.9

—

Brain glioblastoma, helper endpoint

2.81

3.45

3.2

4.4

—

Malignant neoplasm of renal pelvis, including Hilmo

4.62

3.45

6.0

4.6

—

Emphysema

296

1.73

3.42

3.6

5.0

—

Other leukaemias of specified cell type

6.14

3.42

19.6

3.9

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.69

3.41

6.1

3.7

—

Malignant neoplasm of cervix uteri, including Hilmo

3.55

3.41

1.4

1.8

—

Other and unspecified injuries of shoulder and upper arm

120

2.19

3.39

3.4

4.0

—

Use of fingolimod

5.10

3.39

2.2

4.6

—

Calculus of lower urinary tract

231

1.83

3.39

3.6

4.4

—

Other hammer toe(s) (acquired)

100

620

1.47

3.37

3.5

3.7

—

Functional dyspepsia

154

1136

1.36

3.37

3.5

3.7

—

Dermatophytosis, including avohilmo

397

3222

1.21

3.37

3.9

3.5

—

Polyarthritis, unspecified

127

2.15

3.36

3.4

4.4

—

Focal brain injury

224

1.84

3.36

4.7

4.9

—

Other specified/unspecified nutritional deficiencies

4.47

3.34

5.7

4.4

—

Wet age-related macular degeneration

128

884

1.40

3.34

3.9

4.0

—

Anosmia

3.73

3.33

3.8

1.4

—

Deep endometriosis

306

1.71

3.33

2.3

3.6

—

Use of amantadine

2.66

3.32

3.5

4.2

—

Irregular menses

225

1311

1.29

3.32

3.0

—

Atopic dermatitis, strict definition

154

1113

1.36

3.32

3.1

3.6

—

Benign neoplasm: Cerebral meninges

383

1.63

3.31

4.1

3.9

—

ILD medications: pirfenidone

4.01

3.31

3.0

4.3

—

Other meningitis

2.96

3.31

3.6

3.1

—

Iron deficiency

2.43

3.31

4.2

4.4

—

Acne vulgaris

232

1.82

3.31

2.4

3.0

—

Abnormal findings on examination of urine, without diagnosis

176

1.95

3.30

3.4

4.3

—

Speech and linguistic disorders, excluding more controls

259

1.75

3.30

5.3

3.7

—

Traumatic subdural haemorrhage

566

1.49

3.28

3.9

3.8

—

Superficial injury of shoulder and upper arm

463

1.56

3.26

4.5

4.2

—

Exfoliative dermatitis

3.41

3.25

6.4

4.1

—

Adenocarcinoma and ductal carcinoma of pancreas

2.35

3.25

1.4

2.9

—

Status epilepticus

129

2.11

3.25

3.9

5.4

—

Other disorders of central nervous system

3.40

3.24

2.9

4.1

—

Xerosis cutis

2.71

3.24

5.8

4.1

—

Precocious puberty

5.51

3.22

2.0

7.1

—

Family history of certain disabilities and chronic diseases leading to disablement

116

2.17

3.22

3.6

2.9

—

Disorders of psychological development

422

1.57

3.22

4.1

3.4

—

Implicit parasitic Sepsis

6.56

3.21

3.6

4.1

—

Ductal carcinoma of pancreas

5.45

3.21

1.3

3.9

—

Colitis, primary sclerosing

2.91

3.21

2.7

3.2

—

Chondromalacia

2.29

3.21

2.3

3.6

—

Malignant neoplasm of tonsil

4.22

3.20

4.3

4.9

—

Other inflammation of eyelid

594

1.49

3.19

4.5

4.0

—

Tuberculosis

243

1.78

3.19

4.3

4.2

—

Erosion and ectropion of cervix uteri

2.33

3.18

2.2

3.4

—

Malnutrition

104

2.24

3.18

2.4

4.5

—

Universal erythroderma, KELA reimbursement

2.78

3.18

2.8

4.6

—

Dislocation, sprain and strain of joints and ligaments of thorax

117

2.16

3.17

2.6

3.8

—

Pure hyperglyceridaemia

2.38

3.17

4.0

4.9

—

Mouth breathing

148

1975

0.75

3.16

3.8

3.9

—

Benign neoplasm: Skin of other and unspecified parts of face

443

1.57

3.16

4.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

388

1.61

3.16

3.2

4.3

—

Unspecific neurodegenerative disorder

202

1779

0.78

3.16

3.9

3.8

—

Allergic contact dermatitis due to drugs in contact with skin

2.44

3.15

3.3

3.7

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

2.66

3.15

4.7

4.1

—

Optic atrophy

2.51

3.15

7.8

4.2

—

Other epidermal thickening

165

1.96

3.15

5.1

4.2

—

Other orthopaedic follow-up care

179

1.91

3.14

2.5

3.8

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

222

1.81

3.14

3.5

4.6

—

Morphin

2.56

3.14

2.4

4.5

—

Nonorganic sleeping disorders, excluding more controls

102

711

1.44

3.13

3.0

3.7

—

Dependence on enabling machines and devices, not elsewhere classified

3.00

3.13

5.5

3.7

—

Benign paroxysmal vertigo

186

1428

1.31

3.13

3.2

3.8

—

Dementia in other diseases classified elsewhere

201

1.86

3.12

2.4

4.5

—

Polymyositis

3.76

3.12

4.3

4.2

—

Unspecified/other endometriosis

254

1.74

3.11

2.8

3.1

—

Endometriosis of rectovaginal septum and vagina

245

1.76

3.10

2.4

3.4

—

Covid-19 suspected case

109

771

1.42

3.10

4.1

3.6

—

Malignant neoplasm of tonsil, including Hilmo

3.71

3.10

4.1

4.3

—

Memory loss

401

0.45

3.09

3.3

4.3

—

Trochanteric bursitis

566

1.49

3.08

3.8

—

Optic atrophy, wide definition

2.47

3.07

7.8

4.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

173

1320

1.31

3.05

3.4

4.0

—

Familial chondrocalcinosis

10.98

3.05

7.4

6.2

—

Other menopausal disorders

574

0.65

3.04

3.6

3.1

—

Malignant neoplasm of larynx, including Hilmo

2.92

3.03

3.6

3.5

—

Other complications of labour and delivery, not elsewhere classified

253

0.35

3.03

2.1

2.6

—

Benign neoplasm: Adrenal gland

315

1.66

3.03

3.4

4.2

—

L02BX Other hormone antagonists and related agents

293

1.69

3.01

2.1

4.5

—

Thyroiditis

233

1.77

3.00

2.8

3.9

—

Acute gastritis

278

1.70

2.99

3.6

3.7

—

Malignant neoplasm of other and unspecified parts of tongue

3.90

2.99

1.8

3.5

—

Use of rivastigmine

830

0.62

2.99

3.4

4.0

—

Respiratory tuberculosis, confirmed

2.66

2.98

6.7

3.7

—

Iridocyclitis in diseases classified elsewhere

2.50

2.97

2.1

3.6

—

Emotional disorders and disorders of social functioning with onset specific to childhood

200

1.82

2.97

4.1

3.4

—

Open wound of hip and thigh

114

2.12

2.95

4.1

4.2

—

Type 1 diabetes

141

1049

1.35

2.95

3.8

3.9

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

3.28

2.94

3.4

2.9

—

Other peripheral vertigo

380

1.59

2.94

3.6

4.2

—

Carcinoma in situ of skin

388

1.58

2.94

7.7

4.2

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

4.79

2.93

1.9

3.6

—

Rheumatoid lung disease

4.27

2.93

7.3

4.0

—

Alcohol-induced chronic pancreatitis

235

1.76

2.93

2.3

4.9

—

Other enthesopathies

158

1198

1.32

2.92

3.2

3.8

—

Symptoms and signs involving the nervous and musculoskeletal systems

366

3056

1.20

2.92

4.0

3.7

—

Cyclic neutropenia

7.13

2.92

6.3

5.4

—

Other coagulation defects

265

1.71

2.92

3.6

—

Acne, including avohilmo

101

574

1.43

2.92

3.4

3.0

—

Carcinoma in situ of skin of trunk

142

1.99

2.91

10.1

4.3

—

Chronic nephritic syndrome

142

1.99

2.91

6.0

4.3

—

Hereditary hypogammaglobulinemia

5.62

2.91

2.7

3.0

—

Scleritis and episcleritis

206

1.81

2.91

3.5

3.8

—

Tinnitus

140

1045

1.34

2.90

3.6

4.0

—

Residual foreign body in soft tissue

163

1.91

2.90

2.9

4.6

—

Acute mastoiditis

3.78

2.90

3.3

3.2

—

Nonalcoholic steatohepatitis

3.78

2.90

1.6

4.7

—

Pemphigoid

115

2.11

2.90

4.1

4.7

—

Mesothelioma, including Hilmo

3.76

2.89

3.1

4.2

—

Type 1 diabetes, wide definition, subgroup 1

111

798

1.39

2.89

3.6

3.8

—

Disorder of the sleep-wake schedule

2.53

2.89

2.4

4.7

—

Superficial injury of lower leg

150

1132

1.33

2.88

3.2

3.8

—

Delivery, wide proxy

116

847

0.72

2.88

3.5

3.3

—

Oral leukoplakia, including avohilmo

102

2.18

2.88

4.1

4.0

—

Hyperprolactinaemia

2.26

2.87

6.5

3.1

—

Polycystic ovarian syndrome

122

2.06

2.87

3.0

3.2

—

Vulvovaginal ulceration/inflammation in other diseases

178

1.86

2.86

3.0

3.5

—

Other eating disorders

143

1.97

2.84

4.0

3.5

—

Endometriosis ASRM stages 3,4

112

810

1.39

2.84

2.7

3.4

—

Diplopia

536

1.48

2.84

5.4

4.1

—

Endometriosis of ovary

542

1.46

2.84

2.9

3.1

—

Lichen simplex chronicus

116

2.09

2.83

3.4

4.4

—

Blindness or visual impairment, binocular

4.59

2.82

3.1

4.1

—

Dermatopolymyositis, unspecified

4.59

2.82

5.5

3.7

—

Malignant neoplasm of testis

3.37

2.82

5.2

3.2

—

Thyrotoxicosis with diffuse goitre

496

1.50

2.82

3.5

4.1

—

Malignant neoplasm of floor of mouth, including Hilmo

4.53

2.81

5.6

3.6

—

Felty syndrome

4.05

2.81

5.9

3.7

—

Hydrocephalus in other diseases

4.04

2.80

4.9

3.7

—

Other benign neoplasms of uterus

194

1.82

2.80

2.5

3.4

—

Medullary cystic kidney disease, nephronophthisis

8.94

2.80

7.6

4.7

—

Lesion of ulnar nerve

505

1.49

2.80

3.8

4.0

—

Kaposi sarcoma, including Hilmo

8.92

2.80

4.2

5.8

—

219

0.36

2.78

2.9

2.8

—

Antenatal screening

393

0.60

2.78

2.2

2.8

—

Benign neoplasm: Lymph nodes

8.69

2.78

1.6

4.7

—

Miliary tuberculosis

6.48

2.76

2.3

4.7

—

Deep bite

429

1.50

2.76

3.1

3.8

—

Thoracic aortic aneurysm

697

1.41

2.76

3.5

4.1

—

Benign neoplasm: Connective and other soft tissue of thorax

5.16

2.75

4.3

3.2

—

Isolated growth hormone deficiency

2.68

2.75

4.2

5.6

—

Renal cell carcinoma of kidney

2.33

2.75

2.9

3.0

—

Cachexia

5.13

2.75

1.4

3.4

—

Superficial injury of abdomen, lower back and pelvis

614

1.44

2.75

4.5

3.8

—

Benign neoplasm: Ascending colon

681

1.42

2.74

3.6

4.1

—

Infective bursitis

111

2.09

2.74

3.0

5.0

—

Schizoaffective disorder

233

1.73

2.72

3.3

3.5

—

Other and unspecified vasculitis limited to skin

2.26

2.71

4.7

3.7

—

Adenocarcinoma and papillary adenocarcinoma of stomach

2.44

2.71

1.7

3.2

—

Vitreous haemorrhage

412

1.54

2.71

5.1

4.1

—

Tooth eruption problems

499

1.47

2.70

4.0

3.1

—

Other and unspecified nonscarring hair loss

4.29

2.69

1.4

3.7

—

Entropion and trichiasis of eyelid

373

1.56

2.69

4.6

—

Short stature, not elsewhere classified

129

1.97

2.68

5.1

4.5

—

Cervicalgia

122

905

1.35

2.67

3.2

3.8

—

Primary coxarthrosis, bilateral

192

1516

1.27

2.66

3.3

3.8

—

Benign neoplasm: Skin, unspecified

140

1.94

2.66

3.1

4.1

—

Hyperhidrosis

2.34

2.65

3.8

3.1

—

Otalgia

343

1.58

2.64

3.6

4.2

—

Carcinoma in situ of breast, intraductal

312

1.61

2.64

3.1

3.7

—

Respiratory tuberculosis, confirmed, including avohilmo

2.49

2.63

6.7

3.5

—

Nummular dermatitis

328

1.59

2.63

3.1

3.8

—

Superficial injury of head

151

1157

1.31

2.62

2.6

4.0

—

Hypersensitivity angiitis

4.81

2.62

2.3

4.2

—

Respiratory conditions due to other external agents

2.28

2.62

5.1

4.3

—

Carcinoma in situ of vagina

4.78

2.61

3.0

2.4

—

Congenital absence, atresia and stenosis of small intestine

7.84

2.61

1.6

5.9

—

Benign neoplasm of other and unspecified female genital organs

134

1.96

2.61

2.4

3.4

—

Cardiomyopathy in other diseases

3.71

2.60

3.9

4.4

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

127

1.98

2.60

4.4

3.6

—

Pyoderma

2.33

2.59

4.9

4.3

—

Delayed milestone in childhood

133

1.93

2.59

2.1

5.3

—

Cardiac arrest

193

1.72

2.59

2.3

3.3

—

Fall involving bed

163

1.86

2.59

2.9

4.5

—

Sequelae of injuries of head

192

1.78

2.58

2.8

4.7

—

Benign neoplasm: Tongue

107

2.08

2.58

7.3

4.3

—

Migraine

252

1596

1.23

2.58

2.5

3.5

—

Superficial injury of forearm

385

1.54

2.58

3.9

4.2

—

Hypoglycaemia, other or unspecified

268

1.65

2.56

3.9

4.5

—

Suggestive for eosinophilic asthma

346

1.57

2.56

3.3

4.6

—

Malignant neoplasm of floor of mouth

5.59

2.56

5.3

4.1

—

Mental and behavioural disorders due to cannabinoids

2.37

2.56

2.9

—

Superficial injury of thorax

615

1.42

2.56

3.2

4.1

—

Alcohol withdrawal state with delirium

261

1.66

2.54

1.9

4.5

—

Abnormal serum enzyme levels

129

1636

0.76

2.54

4.2

3.9

—

Lactose intolerance

101

2.10

2.53

1.9

4.3

—

Exophthalmic conditions

3.28

2.53

3.0

4.6

—

Family history of malignant neoplasm

347

1.56

2.53

3.2

3.0

—

Malignant neoplasm of vulva, including Hilmo

3.27

2.53

2.2

2.6

—

Disorder of external ear, unspecified

122

1.98

2.51

2.6

4.5

—

Urethral stricture

239

1.68

2.51

4.5

4.2

—

Intracerebral haemorrhage

584

1.43

2.51

3.7

4.7

—

Invasive ventilation

314

0.44

2.51

4.7

4.2

—

Failed induction of labour

136

1.92

2.50

2.7

3.1

—

Coeliac disease

469

1.48

2.50

4.0

—

Implicit parasitic Sepsis, including avohilmo

4.48

2.49

3.6

—

Other congenital malformations of the digestive system

208

1.73

2.49

3.7

4.9

—

Thyrotoxicosis

140

1073

1.31

2.47

3.6

3.7

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

266

1.63

2.47

3.4

3.7

—

Sixth [abducent] nerve palsy

137

1.92

2.47

4.4

4.9

—

Drug-induced hypoglycaemia without coma

2.49

2.46

1.8

4.5

—

Causalgia

2.70

2.46

2.8

4.3

—

Certain conditions originating in the perinatal period

302

1.56

2.46

4.0

3.5

—

Impacted teeth

573

1.40

2.46

4.1

3.0

—

Heart failure and hypertrophic cardiomyopathy

2.27

2.46

2.9

3.9

—

Bacterial, viral and other infectious agents

295

1.60

2.44

6.6

3.9

—

Vasculitis limited to skin, not elsewhere classified

2.10

2.44

4.5

3.7

—

Benign neoplasm: Skin of ear and external auricular canal

152

1.86

2.43

6.0

4.6

—

Aortic aneurysm

156

1192

1.29

2.43

3.2

3.9

—

Severe visual impairment, monocular

2.95

2.43

2.5

4.4

—

Carcinoma in situ of skin, other sites/unspecified

2.32

2.43

5.2

3.8

—

Supernumerary teeth EXCLUDE clefts and syndromes

5.14

2.42

1.5

8.1

—

Emotional disorders starting during childhood or adolescence

187

1.76

2.41

4.5

3.5

—

Whooping cough

5.09

2.41

1.8

3.0

—

Other aneurysm

242

1.66

2.41

3.1

4.7

—

Eating disorders

327

1.56

2.41

3.0

3.3

—

Other endocrine disorders

232

1.66

2.39

4.6

4.1

—

Other osteochondropathies

235

1.67

2.38

3.7

4.2

—

Pre-eclampsia superimposed on chronic hypertension

6.37

2.38

5.6

5.9

—

Eustachian salpingitis and obstruction

235

1.67

2.38

4.9

3.7

—

Disorders of plasma-protein metabolism, not elsewhere classified

3.72

2.38

11.5

4.3

—

Other/unspecified enthesopathies, not elsewhere classified

305

1.58

2.38

3.4

4.0

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.54

2.37

5.5

4.3

—

Use of anticholinesterases

165

1609

0.79

2.37

3.4

3.8

—

N06DA Anticholinesterases

165

1609

0.79

2.37

3.4

3.8

—

Benign neoplasm: Spinal meninges

3.08

2.37

2.6

4.1

—

Plantar fascial fibromatosis

337

1.55

2.37

3.3

4.1

—

Embedded teeth, including avohilmo

274

1.61

2.37

2.0

3.5

—

Malignant neoplasm of larynx

3.06

2.36

4.4

4.0

—

Coronary atherosclerosis

414

2239

1.17

2.36

3.9

3.8

—

Other benign neoplasm of uterus: Other parts/unspecified

161

1.82

2.36

2.4

3.4

—

severe traumatic brain injury, does not include concussion

140

1081

1.30

2.36

4.1

3.9

—

Female infertility, associated with anovulation

168

1.79

2.36

2.8

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

2.84

2.35

1.8

3.6

—

Excessive attrition of teeth

342

2875

1.18

2.33

3.6

3.5

—

Persons encountering health services for specific procedures, not carried out

263

0.42

2.33

2.2

4.2

—

Alcohol abuse, main dg

585

1.41

2.32

1.9

4.2

—

Bacterial, viral and other infectious agents, including avohilmo

315

1.56

2.32

6.3

4.0

—

Other superficial mycoses

2.20

2.32

4.1

3.6

—

Corneal ulcer

712

1.37

2.32

2.6

3.9

—

Other nonscarring hair loss

3.26

2.32

1.3

3.0

—

Other degenerative diseases of the nervous system

165

946

1.27

2.31

3.9

3.8

—

Superficial injury of wrist and hand

114

858

1.33

2.31

2.4

3.7

—

Recurrent dislocation and subluxation of joint

184

1.75

2.31

2.2

4.5

—

Valvular operations

653

1.38

2.31

3.6

4.0

—

Eating disorder

252

1.63

2.31

3.3

3.2

—

Testicular hypofunction

119

1.95

2.31

5.0

4.6

—

Disseminated intravascular coagulation [defibrination syndrome]

4.80

2.30

4.2

3.5

—

Fluid overload

4.79

2.30

1.3

3.6

—

Ectropion of eyelid

170

1.78

2.29

2.8

4.4

—

Perichondritis of external ear

2.25

2.29

5.3

4.0

—

Other dermatomyositis

4.73

2.29

4.0

4.7

—

Malignant neoplasm of other and unspecified female genital organs

2.97

2.29

1.5

1.8

—

Isolated proteinuria with specified morphological lesion

2.60

2.29

2.9

4.2

—

Malignant neoplasm of other and unspecified parts of mouth

4.71

2.28

2.2

3.9

—

Arthropathy in ulcerative colitis

2.79

2.28

3.0

3.9

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

454

1.46

2.28

4.9

4.1

—

Autoimmune hepatitis

3.53

2.28

1.9

4.1

—

Mesothelioma

3.53

2.28

3.3

—

Type 1 diabetes, wide definition

115

868

1.33

2.28

3.5

3.8

—

Inflammatory disease of uterus

397

1.49

2.27

2.8

3.4

—

Supervision of normal pregnancy

379

0.63

2.27

2.4

2.8

—

Disorders of adrenal gland, other and/or unspecified

3.99

2.27

4.6

3.1

—

Benign neoplasm: Orbit, unspecified

3.97

2.27

3.6

2.7

—

Tuberculosis of other organs

2.18

2.26

4.0

4.6

—

Prepatellar bursitis

156

1.81

2.26

3.2

4.1

—

Viral meningitis, including avohilmo

106

1.99

2.26

4.0

3.7

—

Background retinopathy and retinal vascular changes

2.18

2.26

1.8

4.2

—

Paroxysmal tachycardia

108

670

1.34

2.25

4.1

3.5

—

Cervicobrachial syndrome

931

0.70

2.25

3.9

3.8

—

Peritonsillar abscess

707

1.36

2.25

3.5

3.8

—

Abscess of mediastinum

5.90

2.25

1.4

1.9

—

Rheumatic heart disease, other

5.89

2.25

2.0

3.7

—

Salpingitis and oophoritis

648

1.38

2.25

2.5

3.5

—

Cerebral oedema

5.85

2.24

2.6

—

Chronic suppurative otitis media

247

1.63

2.24

3.2

3.9

—

Exposure to uncontrolled fire in building or structure

3.17

2.24

2.2

3.8

—

Umbilical hernia

161

1275

1.27

2.24

3.8

4.0

—

Other conditions related to polyarteritis nodosa

5.80

2.24

2.8

3.6

—

Atypical virus infections of central nervous system

3.16

2.24

4.3

3.1

—

Diabetes insipidus

3.16

2.24

3.8

3.4

—

Tuberculosis of other organs, strict

2.11

2.24

3.8

4.4

—

Congenital malformations of genital organs

316

1.55

2.23

3.8

3.9

—

Lumbosacral plexus disorders

5.74

2.23

2.2

4.6

—

Algoneurodystrophy

2.11

2.23

4.1

4.0

—

Whooping cough, including avohilmo

3.13

2.23

2.8

2.7

—

Pneumonia due to Haemophilus influenzae

5.70

2.23

11.2

2.7

—

Scleritis

2.72

2.22

3.1

3.7

—

Benign neoplasm of brain and other parts of central nervous system

248

1.62

2.22

3.1

4.4

—

Intentional self-harm by unspecified means

2.72

2.22

2.1

4.3

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

187

1.72

2.21

7.5

4.1

—

Other salmonella infections

114

1.94

2.21

4.6

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

150

1.81

2.21

4.4

3.8

—

Symptoms and signs involving speech and voice

197

1600

1.23

2.20

2.9

3.8

—

Appendectomy

351

2859

1.17

2.19

3.7

3.5

—

Other localized connective tissue disorders

2.26

2.18

6.2

3.8

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.09

2.18

3.0

4.3

—

Disorders of tooth development and eruption

425

1.42

2.18

3.3

3.4

—

Disorders of other and unspecified cranial nerves

3.78

2.17

2.4

5.8

—

Malignant neoplasm of thyroid gland, including Hilmo

173

1.74

2.16

6.6

2.7

—

Atypical virus infections of central nervous system, including avohilmo

3.05

2.16

4.3

3.0

—

Nonpyogenic thrombosis of intracranial venous system

3.05

2.16

8.3

4.1

—

Sequelae of injuries of lower limb

329

1.53

2.16

4.7

4.1

—

Viral meningitis

101

1.99

2.16

4.1

3.7

—

Other nutritional anaemias

3.04

2.15

6.0

3.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

120

916

0.77

2.15

2.7

3.0

—

Other and unspecified pemphigoid

2.83

2.15

4.0

3.8

—

Episcleritis

166

1.76

2.15

3.4

3.9

—

Dilated cardiomyopathy

527

1.41

2.15

3.7

4.4

—

Agoraphobia

2.17

2.15

4.0

3.8

—

Congenital malformations of uterus and cervix

2.80

2.14

4.0

2.6

—

Acute nephritic syndrome

2.12

2.14

2.1

4.8

—

Open bite

189

1.70

2.13

4.6

4.2

—

Tuberculosis of other organs, strict, including avohilmo

2.07

2.12

3.8

4.4

—

Atlantoaxial subluxation

3.27

2.11

6.1

3.5

—

Sequelae of injuries of neck and trunk

109

1.94

2.11

2.4

4.1

—

Hypogonadotropic hypogonadism

102

1.98

2.11

5.7

4.7

—

Disturbance of activity and attention

419

1.45

2.09

2.4

2.9

—

Flat foot [pes planus] (acquired)

332

1.51

2.08

3.7

3.8

—

Melanocytic naevi of trunk

455

1.43

2.08

3.9

4.1

—

Migraine with aura

113

864

1.31

2.08

2.8

3.5

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

229

1.62

2.08

3.5

4.1

—

Marasmic kwashiorkor

4.21

2.07

2.0

3.4

—

Other disorders of eyelid

279

2224

1.19

2.07

3.5

3.8

—

AV-block

115

752

1.31

2.07

3.6

3.8

—

Generalized epilepsy, strict definition

2.04

2.07

3.3

3.9

—

Injury of blood vessels of thorax

4.13

2.06

3.3

4.1

—

Seronegative juvenile rheumatoid arthritis

2.34

2.05

3.0

5.4

—

Abdominal aortic aneurysm (AAA)

469

1.42

2.05

2.6

4.3

—

Glucosamine medication

300

2034

1.18

2.05

3.0

3.9

—

Wilms' tumor, including Hilmo

4.08

2.05

1.5

3.9

—

Varicose veins of other sites

238

1.60

2.04

4.3

4.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

233

1.61

2.04

4.3

3.7

—

Effects of foreign body entering through natural orifice

133

1043

1.28

2.04

3.1

4.0

—

Benign neoplasm of eye and adnexa

441

1.43

2.03

3.2

3.9

—

Generalized epilepsy

147

1.78

2.03

3.7

4.0

—

Collapsed vertebra, not elsewhere classified

3.13

2.02

3.4

3.7

—

Guttate psoriasis

2.53

2.02

5.3

4.0

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.67

2.02

1.3

7.0

—

Dislocation, sprain and strain of joints and ligaments of knee

327

2535

1.17

2.01

3.0

3.6

—

Trigger finger

559

1.38

2.01

3.4

3.9

—

Benign neoplasm: Vagina

2.85

2.01

2.1

3.6

—

Complications of other internal prosthetic devices, implants and grafts

155

1.75

2.00

4.0

3.8

—

Polycystic ovarian syndrome, broad definition

247

1.58

2.00

2.8

2.9

—

Malignant neoplasm of thyroid gland

155

1.75

2.00

6.5

2.7

—

Other intracranial haemorrhages

148

1.77

1.99

5.4

5.3

—

Barrett oesophagus

201

1.65

1.99

2.8

3.7

—

Benign neoplasm: Brain, supratentorial

2.31

1.99

3.0

3.2

—

Migraine with aura and triptan purchases

510

1.40

1.98

2.5

3.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

270

2266

1.18

1.98

3.9

3.6

—

Dysplasia of cervi uteri

103

548

1.32

1.97

3.6

2.9

—

Non-allergic asthma

375

0.56

1.97

3.6

4.3

—

Vascular diseases of the intestine

171

1.71

1.97

3.1

4.8

—

Need for other prophylactic measures

225

1.61

1.96

6.6

4.2

—

Left hemicolectomy

2.04

1.96

3.9

4.3

—

Unspecified event, undetermined intent

2.04

1.96

2.9

4.1

—

Biliary cirrhosis, NAS

4.70

1.96

2.0

4.5

—

Other symptoms and signs involving the nervous and musculoskeletal systems

246

2069

1.19

1.96

4.1

3.7

—

Hypertension, portal

3.89

1.96

2.7

4.0

—

Volvulus

1.95

1.96

2.5

4.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocyte morphology finding [Identifier] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS